Page last updated: 2024-08-24

fluorodeoxyglucose f18 and Cognitive Dysfunction

fluorodeoxyglucose f18 has been researched along with Cognitive Dysfunction in 387 studies

Research

Studies (387)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	260 (67.18)	24.3611
2020's	127 (32.82)	2.80

Authors

Authors	Studies
Eo, JS; Han, CE; Hyung, WSW; Jeong, HG; Lee, ES; Suh, S; Youn, H	1
Choi, H; Kim, JM; Lee, R; Park, KY; Seok, JW	1
Altmann, A; Dawson, SJ; Scelsi, MA; Zainul Abidin, FN	1
Arnaldi, D; Bauckneht, M; Biassoni, E; Brugnolo, A; Chincarini, A; Donegani, MI; Girtler, N; Guerra, UP; Massa, F; Mattioli, P; Morbelli, S; Nobili, F; Orso, B; Pagani, M; Pardini, M; Peira, E; Raffa, S	1
Aikawa, M; Aso, Y; Kimura, N; Matsubara, E; Sasaki, Y; Yabuuchi, K	1
Casagrande, CC; Johnson, CM; May, PE; Mundorf, VM; Murman, DL; Wiesman, AI; Wilson, TW; Wolfson, SL	1
Arahata, Y; Bundo, M; Ikenuma, H; Ito, K; Iwata, K; Kato, T; Kimura, Y; Nakamura, A; Nihashi, T; Okamura, N; Sakurai, K; Sakurai, T; Suzuki, K; Takeda, A; Washimi, Y; Yamaoka, A; Yanai, K	1
Abdolalizadeh, A; Ashraf-Ganjouei, A; Faghani, S; Fatehi, F; Khomeijani-Farahani, M; Moradi, K	1
Drzezga, A; Eggers, C; Greuel, A; Jessen, F; Kalbe, E; Krohm, F; Maier, F; Ophey, A; Timmermann, L; Tittgemeyer, M	1
Abe, M; Eguchi, A; Kimura, N; Matsubara, E; Sasaki, Y	1
An, Y; Li, W; Liu, M; Lu, J; Qi, Z; Qiao, L; Wang, G; Yan, S; Zhao, Z	1
Ahn, H; Byun, MS; Chu, K; Han, D; Joung, H; Jung, G; Lee, DY; Lee, JH; Lee, Y; Sung, K; Yi, D	1
Apostolova, I; Buchert, R; Grothe, MJ; Lange, C; Mäurer, A; Steffen, IG; Suppa, P	1
Arias, JF; Benedet, A; Bezgin, G; Bunai, T; Kang, MS; Lussier, F; Matsudaira, T; Obi, T; Ottoy, J; Ouchi, Y; Pascoal, TA; Poltronetti, NM; Rosa-Neto, P; Savard, M; Terada, T; Therriault, J; Tissot, C; Tsukada, H; Wang, YT	1
Alberts, I; Han, Y; Initiative, FTADN; Jiang, J; Li, T; Rominger, A; Shi, K; Sun, X; Wang, M; Zuo, C	1
Ge, Q; Gu, F; Li, P; Li, Y; Lu, J; Ng, YL; Paranjpe, MD; Wang, X; Yan, S; Zhou, Y	1
Liu, Y; Tan, L; Tan, MS; Wang, ZT; Xu, W	1
Guan, Z; Hu, J; Huang, X; Li, B; Li, W; Li, Y; Lin, X; Liu, J; Meng, H; Sun, W; Wang, J; Ye, G; Zhang, M; Zhang, Y	1
Cao, XP; Guo, Y; Han, PR; Hu, H; Liu, Y; Ou, YN; Tan, L; Wang, ZT; Yu, JT	1
Farid, K; Hugon, J; Msika, EF; Paquet, C; Queneau, M; Sanchez Ortiz, M	1
Jang, H; Kim, HJ; Kim, S; Kim, SJ; Kim, YJ; Na, DL; Seo, SW; Woo, SY	1
Appollonio, I; Crivellaro, C; Ferrarese, C; Ferri, F; Formenti, A; Gallivanone, F; Guerra, L; Isella, V; Mapelli, C; Morzenti, S; Musarra, M; Pacella, S	1
Jeon, B; Kim, H; Kim, YK; Lee, JY; Nam, H; Shin, JH; Yoo, D; Yoon, EJ	1
Chen, G; Han, Y; Jiang, J; Jiang, X; Jin, S; Li, L; Liu, C; Sheng, C	1
Bernardini, S; Camedda, R; Chiaravalloti, A; Fernandes, M; Giambrone, MP; Izzi, F; Liguori, C; Mari, L; Mercuri, NB; Nuccetelli, M; Paoli, B; Placidi, F; Schillaci, O	1
Bladowska, J; Sąsiadek, M; Statkiewicz, M; Trypka, E; Wabik, A; Zimny, A	1
Aluisantonio, L; Chiaravalloti, A; Di Santo, S; Fernandes, M; Franchini, F; Izzi, F; Liguori, C; Manfredi, N; Mercuri, NB; Placidi, F; Schillaci, O	1
Álvarez-Sanchez, L; Aparici-Robles, F; Baquero-Toledo, M; Cerdá-Alberich, L; Cháfer-Pericás, C; Gandia-Ferrero, MT; Gómez-Rico, I; Martí-Bonmatí, L; Martínez-Sanchis, B; Prats-Climent, J; Rodríguez-Álvarez, MJ; Torres-Espallardo, I	1
Alavi, A; Coble, R; Khosravi, M; Newberg, AB	1
Asken, BM; Edwards, L; Gorno-Tempini, ML; Iaccarino, L; Kramer, JH; La Joie, R; Malpetti, M; Mellinger, T; Miller, BL; Miller, Z; Mundada, NS; Perry, DC; Pham, J; Possin, K; Rabinovici, GD; Rosen, HJ; Soleimani-Meigooni, DN; Strom, A; Tanner, JA	1
Eidelberg, D; Emeršič, A; Jamšek, J; Perovnik, M; Tang, C; Tomše, P; Trošt, M	1
Bischof, GN; Bohn, KP; Doering, E; Drzezga, A; Ellingsen, LM; Hoenig, MC; van Eimeren, T	1
Chen, H; He, X; Liu, Y; Qing, L; Xu, Y; Zhang, J	1
Allali, G; Altomare, D; Assal, F; Caprioglio, C; Frisoni, GB; Frölich, L; Garibotto, V; Jessen, F	1
Crowson, CS; Davis Iii, JM; Duong, SQ; Jones, DT; Mielke, MM; Myasoedova, E; Nguyen, A; Vassilaki, M; Vemuri, P	1
Dartora, CM; de Moura, LV; Koole, M; Marques da Silva, AM	1
Booth, S; Ko, JH; Lee, CS; Park, KW	1
Albensi, BC; Beheshti, I; Geddert, N; Gupta, V; Ko, JH; Perron, J	1
Agnello, L; Blandino, V; Ciaccio, M; Colletti, T; Gambino, CM; Giglio, RV; Graziano, F; Guajana, F; La Bella, V; Lo Sasso, B; Maniscalco, L; Matranga, D; Piccoli, T	1
Feng, Y; Kim, M; Liu, K; Long, Q; Shen, L; Yao, X	1
Hu, Y; Ning, Y; Shi, X; Sun, B; Wu, Y; Zhou, N	1
Chen, Y; Cheng, J; Liu, F; Wang, H; Wei, S	1
Byun, JI; Choi, H; Jung, KY; Ryoo, HG	1
Snekhalatha, U; Thakur, M	1
Bertels, J; Coolen, T; De Tiège, X; Goffard, JC; Goldman, S; Henrard, S; Puttaert, D; Rovai, A; Slama, H; Trotta, N; Van Vooren, JP	1
Li, R; Li, W; Lu, J; Qi, Z; Shan, Y; Yan, S; Zhao, Z	1
Hou, J; Jin, H; Peng, J; Qin, X; Shu, Z; Song, Q; Wang, W; Wei, Y; Yuan, Z	1
Gao, X; Gu, Y; Guan, Y; Huang, Q; Jiang, H; Ni, W; Ren, S; Su, J; Weng, R; Xiao, W; Yang, C; Zhang, X	1
Devanand, DP; Masurkar, AV; Wisniewski, T	1
Balabandian, M; Nabizadeh, F; Valizadeh, P	1
Bourgeat, P; Cummins, TL; Doré, V; Elias, A; Feizpour, A; Hopwood, M; Krishnadas, N; Lamb, F; Landau, S; Rowe, CC; Villemagne, VL; Weiner, M; Williams, R	1
Borrie, MJ; Camicioli, R; Chekouo, T; Forkert, ND; Ganesh, A; Hogan, DB; Hsiung, GR; Ismail, Z; Masellis, M; Moorhouse, P; Sajobi, TT; Seitz, DP; Smith, EE; Tartaglia, MC; Wang, M	1
Ahn, JH; Kim, HW; Kong, E; Shin, KC; Son, SH	1
Csoti, I; Drzezga, A; Eggers, C; Greuel, A; Hoock, M; Jessen, F; Kaur, R; Maier, F; Schwartz, F; Tahmasian, M; Timmermann, L; van Eimeren, T	1
Chen, K; Ge, J; Guan, Y; Ju, Z; Lin, H; Lu, J; Nie, B; Pan, T; Shan, B; Wang, M; Wu, P; Zhang, H; Zhao, Q; Zuo, C	1
Eidelberg, D; Namías, M; Perovnik, M; Tang, CC	1
Dong, G; Zhang, ZC; Zhao, X; Zhao, XM	1
Grothe, MJ; Labrador-Espinosa, MA; Mir, P; Moscoso, A; Schöll, M; Silva-Rodríguez, J	1
Boccardi, M; Tang, Y; Teipel, S	1
Kimura, N; Masuda, T; Matsubara, E; Yabuuchi, K	1
Ahmed, R; Breen, N; Fulham, M; McMillan, J; Nikpour, A; Thayer, Z; Zhang, X	1
Braskie, MN; Chui, HC; Hapenney, M; King, K; Mack, WJ; Matsiyevskiy, E; Thompson, PM; Tubi, MA; Wheeler, K	1
Goel, N; Kishore, N	1
Akdemir, UO; Arsava, EM; Atay, LO; Balcı, E; Saka, E; Topcuoglu, MA; Yetim, E	1
Guan, Y; Hua, F; Huang, Q; Liu, J; Ren, S; Su, J; Xie, F; Zhai, Y	1
Albert, NL; Bartenstein, P; Beyer, L; Brendel, M; Buerger, K; Catak, C; Danek, A; Ewers, M; Kazmierczak, P; Levin, J; Meyer-Wilmes, J; Perneczky, R; Pogarell, O; Prix, C; Rominger, A; Schnabel, J; Schönecker, S; Unterrainer, M	1
Ceyssens, S; De Roeck, E; Engelborghs, S; Niemantsverdriet, E; Ottoy, J; Staelens, S; Stroobants, S; Van Broeckhoven, C; Verhaeghe, J; Wyffels, L	1
Dietlein, M; Dillen, K; Dronse, J; Fink, GR; Jacobs, HIL; Kracht, L; Kukolja, J; Langen, KJ; Nellessen, N; Neumaier, B; Onur, OA; Richter, N	1
Amami, J; Azuar, J; Barré, T; Bellivier, F; Clergue-Duval, V; Cognat, E; Dereux, A; Farid, K; Paquet, C; Queneau, M; Questel, F; Vorspan, F	1
Beg, MF; Popuri, K; Yee, E	1
Ahn, BC; Jeong, SY; Kang, K; Ko, PW; Lee, HW; Lee, J; Lee, SW; Son, SH; Yoon, U	1
Chung, SJ; Kim, H; Kim, JS; Lee, CS; Moon, H; Oh, JS; Oh, M	1
Azulay, JP; Boucekine, M; Eusebio, A; Fluchère, F; Grimaldi, S; Guedj, E; Renaud, M; Witjas, T	1
Blazhenets, G; Eidelberg, D; Frings, L; Ma, Y; Meyer, PT; Rücker, G; Schiller, F; Sörensen, A	2
Bauckneht, M; Capello, E; Dottorini, ME; Eusebi, P; Farotti, L; Massa, F; Morbelli, S; Nobili, F; Parnetti, L; Tranfaglia, C	1
Amaro, E; Felício, AC; Ferrari, BL; Gamarra, LF; Lacerda, SS; Mamani, JB; Neto, GCC; Nucci, MP	1
Bouchut, A; Delso, G; Fernandez, B; Giron, A; Habert, MO; Kas, A; Khalifé, M; Sgard, B; Soret, M; Zaslavsky, C	1
Choi, H; Kim, YK; Lee, DS; Lee, JY; Yoon, EJ	1
Alegret, M; Arbizu, J; Boada, M; Buendía, M; Guillen, F; Hernández, I; Martínez-Lage, P; Monleón, I; Munuera, J; Pérez-Grijalba, V; Pesini, P; Prieto, E; Romero, J; Ruiz, A; San-José, I; Sarasa, L; Sarasa, M; Sotolongo-Grau, O; Tárraga, L	1
Bedell, BJ; Carbonell, F; Zijdenbos, AP	1
Irishina, YA; Kataeva, GV; Khomenko, IG; Kropotov, JD; Pronina, MV; Susin, DS	1
Bartenstein, P; Brandt, T; Brendel, M; Buerger, K; Dieterich, M; Engmann, J; Irving, S; Jahn, K; Kohlbecher, S; Kugler, G; la Fougère, C; Perneczky, R; Pradhan, C; Schneider, E; Schöberl, F; Werner, P; Xiong, G; Zwergal, A	1
Detre, JA; Dolui, S; Li, Z; Nasrallah, IM; Wolk, DA	1
Jiang, J; Wang, M; Yan, Z	1
Brucki, SMD; Buchpiguel, CA; Busatto, GF; Coutinho, AM; de Gobbi Porto, FH; de Oliveira, MO; de Paula Faria, D; de Souza Duran, FL; Forlenza, OV; Garcez, AT; Nitrini, R; Ono, CR; Squarzoni, P; Tres, ES	1
Artiges, E; Boutin-Watine, M; Chassoux, F; Landré, E; Laurent, A; Mellerio, C; Semah, F	1
Hotta, M; Imai, K; Kikuchi, Y; Kimura, S; Kinai, E; Kiryu, Y; Komatsu, K; Minamimoto, R; Noguchi, T; Ogata, M; Oka, S; Takano, M; Watanabe, A; Yokoyama, K	1
Bomanji, J; Dickson, J; Diehl, B; Duncan, JS; Jha, A; Nachev, P; Smith, AL; Teotonio, R	1
Boles Ponto, LL; DeVries, SD; Harlynn, EL; Magnotta, VA; Menda, Y; Moser, DJ; Oleson, JJ; Schultz, SK; Wemmie, JA	1
Hu, B; Hu, T; Li, Y; Teng, L; Yao, Z; Zhang, Z; Zhao, Y	1
Alberts, I; Ge, J; Jiang, J; Rominger, A; Shi, K; Wang, M; Yan, Z; Yu, J; Zhang, H; Zuo, C	1
Agosta, F; Caminiti, SP; Caso, F; Cecchetti, G; Filippi, M; Magnani, G; Martinelli, V; Masserini, F; Passerini, G; Perani, D; Pinto, P; Sala, A; Santangelo, R	1
Baroni, M; Bruun, M; Dottorini, ME; Frederiksen, KS; Gjerum, L; Hasselbalch, SG; Henriksen, OM; Koikkalainen, J; Law, I; Lötjönen, J; Mecocci, P; Simonsen, AH	1
Arabi, H; Bortolin, K; Garibotto, V; Ginovart, N; Zaidi, H	1
Buck, A; Delso, G; Huellner, M; Kaushik, S; Kemp, B; Sekine, T; Ter Voert, EEGW; Veit-Haibach, P; Warnock, G; Wiesinger, F	1
Aso, Y; Eguchi, A; Hori, D; Ishibashi, M; Jikumaru, M; Kakuma, T; Kimura, N; Matsubara, E; Nakamichi, A; Obara, H; Sasaki, Y; Sumi, K; Uesugi, S; Yabuuchi, K	1
Bocti, C; Castellano, CA; Croteau, E; Cunnane, SC; Descoteaux, M; Fortier, M; Fulop, T; Houde, JC; Rheault, F; Roy, M; St-Pierre, V; Turcotte, ÉE	1
Alcolea, D; Altuna, M; Annus, T; Barroeta, I; Belbin, O; Benejam, B; Blesa, R; Camacho, V; Carmona-Iragui, M; Clarimón, J; Estellés, T; Fernández, S; Fortea, J; Giménez, S; González-Ortiz, S; Holland, AJ; Illán-Gala, I; Lehmann, S; Lleó, A; Montal, V; Muñoz, L; Osorio, RS; Pegueroles, J; Valldeneu, S; Videla, L; Videla, S; Vilaplana, E; Wilson, LR; Zaman, SH	1
Christianson, TJ; Geda, YE; Jack, CR; Knopman, DS; Krell-Roesch, J; Kremers, WK; Lowe, VJ; Machulda, MM; Mielke, MM; Petersen, RC; Stokin, GB; Syrjanen, JA; Vassilaki, M; Vemuri, P	1
Borsò, E; Ciarmiello, A; Duce, V; Ferrando, O; Foppiano, F; Giovacchini, G; Giovannini, E; Lazzeri, P	1
Kadir, A; Nordberg, A; Perini, G; Rodriguez-Vieitez, E; Sala, A; Savitcheva, I	1
Raji, CA; Silverman, DHS; Torosyan, N	1
Adel, M; Fossati, C; Gaidon, T; Guedj, E; Pan, X; Phan, TL; Wojak, J	1
Jiang, J; Wang, M; Xiao, SY; Yan, Z; Zuo, C	1
Apostolova, I; Buchert, R; Klutmann, S; Lange, C; Mathies, F; Mäurer, A	1
Beyer, L; Blautzik, J; Brendel, E; Brendel, M; Gutzeit, A; Henkel, R; Paolini, M; Pogarell, O; Rominger, A	1
Brucki, SMD; Buchpiguel, CA; Busatto, GF; Costa, NAD; Coutinho, AM; Duran, FLS; Faria, DP; Forlenza, OV; Nitrini, R; Porto, FHG; Squarzoni, P; Yassuda, MS	1
Bettendorff, L; Chen, H; Chen, Z; Cirio, R; Flowers, SA; Fonzetti, P; Franchino-Elder, J; Gerber, LM; Gibson, GE; Grandville, T; Habeck, C; Hirsch, JA; Jordan, B; Luchsinger, JA; Schupf, N; Stern, Y; Xu, H	1
Ewers, M; Franzmeier, N; Neitzel, J; Rubinski, A	1
Blazhenets, G; Frings, L; Meyer, PT; Sörensen, A	1
Apostolova, I; Brenner, W; Buchert, R; Gonzalez-Escamilla, G; Grothe, MJ; Hallab, A; Klutmann, S; Lange, C; Özden, C	1
Choi, N; Chung, SJ; Jo, S; Kim, SJ; Ko, JH; Lee, CS; Lee, EJ; Park, KW; Park, YJ	1
Authier, FJ; Chalaye, J; David, JP; Emsen, B; Evangelista, E; Gracies, JM; Itti, E; Lerman, L; Villafane, G	1
Ataka, T; Kimura, N; Matsubara, E; Mizukami, T; Uchida, H	1
Fukushima, M; Kojima, S; Neuroimaging Initiative, TAD; Tanabe, K; Teramukai, S; Zhou, B	1
Carli, G; Cerami, C; Filippi, M; Iannaccone, S; Magnani, G; Mattoli, MV; Perani, D; Presotto, L; Santangelo, R; Tondo, G	1
Edison, P; Femminella, GD; Harold, D; Scott, J; Williams, J	1
Arena, V; Calvo, A; Canosa, A; Chiò, A; Di Pede, F; Grassano, M; Iazzolino, B; Manera, U; Moglia, C; Pagani, M; Palumbo, F; Peotta, L; Solero, L; Vasta, R	1
Blazhenets, G; Eidelberg, D; Frings, L; Ma, Y; Meyer, PT; Sörensen, A; Wiltfang, J	1
Boccalini, C; Caminiti, SP; Filippi, M; Frisoni, GB; Iannaccone, S; Magnani, G; Perani, D; Presotto, L; Tondo, G	1
Beg, MF; Chausse, G; Jenkins, LM; Ma, D; Popuri, K; Probst, S; Stocks, JK; Wang, L; Yee, E	1
Antelmi, L; Berckel, BV; Bosco, P; Didic, M; Drzezga, A; Frisoni, GB; Garibotto, V; Giannakopoulos, P; Gold, G; Guedj, E; Morbelli, S; Nobili, F; Ossenkoppele, R; Perneczky, R; Rager, O; Ratib, O; Redolfi, A; Tabouret-Viaud, C; Trombella, S	1
Buchert, R; Dyrba, M; Ferreira, D; Grothe, MJ; Lange, C; Levin, F; Teipel, SJ; Westman, E	1
Cabanel, N; Hooshyar Yousefi, B; Kircher, T; Librizzi, D; Luster, M; Riehl, E; Zavorotnyy, M	1
Chang, CJ; Chen, LF; Fuh, JL; Guo, WY; Hsu, TW; Huang, WS; Wang, DW; Wu, HM	1
Bartlett, PF; Jiang, T; Liu, B; Liu, Y; Zhang, Y; Zhou, X; Zhuo, J	1
Blazhenets, G; Bormann, T; Dressing, A; Frings, L; Hosp, JA; Meyer, PT; Schroeter, N; Thurow, J; Wagner, D; Weiller, C	1
Dong, QY; Han, Y; Jiang, JH; Jiang, XY; Li, TR; Wang, XN	1
Arunraj, ST; Baghel, V; Bal, C; Dey, AB; Jaleel, J; Khan, D; Kumar, P; Tripathi, M	1
Ahn, H; Byun, MS; Joung, H; Lee, DY; Lee, JH; Lee, Y; Yi, D	1
Dondaine, T; Drapier, D; Drapier, S; Duprez, J; Guillery, M; Houvenaghel, JF; Le Jeune, F; Riou, A; Robert, G; Sauleau, P; Verin, M	1
Ali, F; Baker, M; Bigio, EH; Botha, H; Buciuc, M; Clark, HM; DeTure, MA; Dickson, DW; Duffy, JR; Ertekin-Taner, N; Fernandez De Castro, CH; Jack, CR; Josephs, KA; Lowe, VJ; Machulda, MM; Martin, PR; Pham, NTT; Polley, EJ; Rademakers, R; Reichard, RR; Reid, RI; Ross, OA; Schwarz, CG; Senjem, ML; Spychalla, AJ; Stierwalt, J; Strand, EA; Utianski, RL; Whitwell, JL	1
Farid, K; Hugon, J; Msika, EF; Paquet, C; Queneau, M	1
Boeve, BF; Botha, H; Chen, Q; Ferman, TJ; Fields, J; Graff-Radford, J; Graff-Radford, N; Gunte, JL; Jack, CR; Jain, M; Jones, DT; Kantarci, K; Knopman, DS; Lesnick, TG; Lowe, VJ; Min, P; Miyagawa, T; Petersen, RC; Przybelski, SA; Savica, R; Schwarz, CG; Senjem, ML	1
Jeon, B; Kim, H; Kim, R; Kim, YK; Lee, JY; Nam, H; Yoo, D; Yoon, EJ	1
Aarsland, D; Agudelo-Cifuentes, M; Bauckneht, M; Brendel, M; Bruffaerts, R; Byttner, S; Camacho, V; Chang, JR; Chincarini, A; Davidsson, A; Etminani, K; Frisoni, GB; Garibotto, V; Kramberger, MG; Lemstra, AW; Martínez-Sanchis, B; Morbelli, S; Nicastro, N; Nobili, F; Ochoa-Figueroa, M; Padovani, A; Pilotto, A; Ressner, M; Rominger, A; Soliman, A; Stegeran, R; Trost, M; van Berckel, BNM; Vandenberghe, R	1
Baker, SL; Edwards, L; Gorno-Tempini, ML; Iaccarino, L; Jagust, WJ; La Joie, R; Landau, SM; Lesman-Segev, OH; Miller, BL; Pham, J; Rabinovici, GD; Rosen, HJ; Soleimani-Meigooni, DN; Strom, A	1
Barker, RA; Brooks, DJ; Burn, DJ; Duncan, GW; Firbank, MJ; Khoo, TK; Lawson, RA; Maxwell, RJ; O'Brien, JT; Petrides, GS; Yarnall, AJ	1
Boccardi, M; Garibotto, V; Herholz, K; Nobili, F; Nordberg, A; Picco, A; Ratib, O; Varrone, A	1
Bejanin, A; Horng, A; Jagust, WJ; Landau, SM; Lockhart, SN; Schreiber, F; Schreiber, S	1
Dahlbom, M; Mason, K; Silverman, DHS; Torosyan, N	1
Becker, JA; Donovan, NJ; Gatchel, JR; Johnson, KA; Locascio, JJ; Marshall, GA; Rentz, DM; Sperling, RA	1
Almkvist, O; Antoni, G; Chiotis, K; Jonasson, M; Leuzy, A; Lubberink, M; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Savitcheva, I; Wall, A	2
Nation, DA; Yew, B	1
Amariglio, RE; Hanseeuw, B; Johnson, KA; Marshall, GA; Munro, CE; Pascual-Leone, A; Rentz, DM; Sperling, RA; Vannini, P	1
Arnaldi, D; Bauckneht, M; Brugnolo, A; Chincarini, A; De Carli, F; Girtler, N; Giuliani, A; Jonsson, C; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Picco, A; Piva, R; Sambuceti, G	1
Almkvist, O; Alongi, P; Bettinardi, V; Cerami, C; Chiotis, K; Gianolli, L; Iaccarino, L; Nordberg, A; Perani, D; Wall, A	1
Bartenstein, P; Blautzik, J; Brendel, M; Ishii, K; Kotz, S; Rominger, A; Sauerbeck, J; Vettermann, F; Winter, Y	1
Bocti, C; Castellano, CA; Croteau, E; Cunnane, SC; Fortier, M; Fulop, T; Paquet, N	1
Alavi, A; Detre, JA; Dolui, S; Nasrallah, IM; Vidorreta, M; Wang, Z; Wolk, DA	1
Frisoni, GB; Guerra, UP; Moretti, DV; Paghera, B; Pievani, M; Pini, L	1
Chen, L; Huang, J; Jin, H; Li, L; Liang, S; Lin, B; Lin, R; Liu, W; Tao, J; Wang, Z; Wu, J; Zhang, Y; Zhuo, P	1
Arnaldi, D; Bauckneht, M; Brugnolo, A; Buschiazzo, A; Chincarini, A; De Carli, F; Girtler, N; Morbelli, S; Nieri, A; Nobili, F; Pagani, M; Pardini, M; Picco, A; Sambuceti, G	1
Auguste, N; Azouani, C; Beauchet, O; Belin, C; Benetos, A; Bertin, H; Blanc, F; Bouteloup, V; Boutoleau-Bretonniére, C; Ceccaldi, M; Chêne, G; Chupin, M; Dartigues, JF; David, R; Dubois, B; Dufouil, C; Fillon, L; Fischer, C; Gabelle, A; Gentric, A; Godefroy, O; Habert, MO; Hanon, O; Harston, S; Hommet, C; Hugon, J; Jalenques, I; Krolak-Salmon, P; Mangin, JF; Moreaud, O; Operto, G; Paccalin, M; Pariente, J; Pasquier, F; Rouaud, O; Rouch, I; Savarieau, H; Sellal, F; Vandel, P; Vellas, B; Wallon, D	1
Cho, J; Furumoto, S; Ido, T; Jeong, HJ; Kang, H; Kang, JM; Lee, H; Lee, KM; Lee, SY; Lee, YB; Na, DL; Noh, Y; Okamura, N; Park, KH; Seo, S; Seong, JK; Shin, DH; Villemagne, VL; Woo, SH; Yanai, K; Yeon, BK	1
Frings, L; Hellwig, S; Meyer, PT; Rücker, G	1
Inui, Y; Ito, K; Kato, T	1
Arnaldi, D; De Carli, F; Dessi, B; Jonsson, C; Leenders, KL; Meles, SK; Morbelli, S; Nobili, F; Pagani, M; Sambuceti, G	1
Chen, X; Gutknecht, J; Hu, B; Majoe, D; Xie, Y; Yao, Z	1
Eliassen, CF; Fladby, T; Grambaite, R; Hessen, E; Reinvang, I; Selnes, P	1
Liu, J; Liu, ZW; Sun, TC; Wang, FJ; Wang, YD; Zhang, XJ	1
Devanand, DP; Kumar, D; Lan, MJ; Mann, JJ; Miller, JM; Ogden, RT; Parsey, RV; Pelton, GH; Pradhaban, G; Rubin-Falcone, H; Stern, Y; Zanderigo, F	1
Aliaga, A; Cuello, AC; Dea, D; Do Carmo, S; Fonov, VS; Gauthier, S; Kang, MS; Kostikov, A; Mathieu, A; Parent, MJ; Poirier, J; Rosa-Neto, P; Shin, M; Soucy, JP; Zimmer, ER	1
Bagnoli, S; Berti, V; Bessi, V; Braccia, A; Del Mastio, M; Matà, S; Nacmias, B; Piaceri, I; Pignone, AM; Polito, C; Pupi, A; Sorbi, S; Tedde, A	1
Buchert, R; Lange, C; Makowski, MR; Peters, O; Pietrzyk, U; Spies, L; Suppa, P	1
Kang, H; Riddle, WR; Shokouhi, S	1
Chen, K; Li, J; Liu, X; Lure, F; Weidman, D; Wu, T	1
Ballarini, T; Caminiti, SP; Cerami, C; Fallanca, F; Gianolli, L; Iannaccone, S; Magnani, G; Perani, D; Presotto, L; Sala, A; Santangelo, R; Vanoli, EG	1
Apostolova, I; Buchert, R; Fiebach, JB; Grothe, MJ; Lange, C; Mäurer, A; Nierhaus, T; Spies, L; Steinhagen-Thiessen, E; Suppa, P	1
Adeli, E; Lee, SW; Shen, D; Thung, KH; Yap, PT	1
Ben Bouallègue, F; Mariano-Goulart, D; Payoux, P	1
Benedet, AL; Gauthier, S; Kang, MS; Mathotaarachchi, S; Nair, V; Ng, KP; Pascoal, TA; Rosa-Neto, P; Shin, M; Struyfs, H; Therriault, J; Walpola, IC	1
Choi, H; Jin, KH	1
Adam, G; Apostolova, I; Buchert, R; Grothe, MJ; Klutmann, S; Lange, C; Spies, L; Suppa, P	1
Bjørnerud, A; Coello, C; Fladby, T; Kalheim, LF; Selnes, P	1
Bormann, T; Buchert, R; Frings, L; Hellwig, S; Meyer, PT; Spehl, TS	1
Kwak, K; Lee, JM; Park, G; Yun, HJ	1
Arnaldi, D; Bauckneht, M; Chincarini, A; Efeturk, H; Girtler, N; Grazzini, M; Massa, F; Morbelli, S; Nobili, F; Pagani, M; Pardini, M; Piva, R; Sambuceti, G	1
Alexander, GE; Bauer, RJ; Caselli, RJ; Chen, K; Chen, Y; Lee, W; Locke, DEC; Reiman, EM; Savage, CR; Sharieff, S; Stonnington, CM; Thiyyagura, P	1
Balachandar, R; Beg, MF; Ding, GW; Lu, D; Popuri, K	1
Cappa, SF; Cerami, C; Dodich, A; Gianolli, L; Iannaccone, S; Magnani, G; Marcone, A; Perani, D; Presotto, L; Santangelo, R	1
Adjouadi, M; Barker, WW; Bauer, RM; Curiel, RE; DeKosky, S; Duara, R; Greig-Custo, MT; Guinjoan, SM; Hanson, KS; Li, C; Lizarraga, G; Loewenstein, DA; Penate, A; Rosselli, M; Torres, V	1
Agosta, F; Altomare, D; Arbizu, J; Barthel, H; Boccardi, M; Bouwman, F; Drzezga, A; Festari, C; Frisoni, GB; Nestor, P; Nobili, F; Orini, S; Rivolta, J; Walker, Z	1
Aiello, M; Baron, JC; Cachia, A; Cavaliere, C; Marchitelli, R; Milan, G; Montella, P; Pappatà, S; Postiglione, A; Quarantelli, M; Salvatore, E; Salvatore, M; Tedeschi, G	1
Banzo, I; Bravo, M; de Arcocha Torres, M; Jimenez Bonilla, J; Kazimierczak, M; Lage, C; Pozueta, A; Quirce, R; Rabinovici, GD; Riancho, J; Rodriguez-Rodriguez, E; Sánchez-Juan, P; Suarez, AG; Vazquez-Higuera, JL	1
Byun, MS; Choi, JE; Im, HJ; Kang, JM; Kim, YK; Lee, DY; Lee, JH; Lee, JY; Ryu, YH; Sohn, BK; Son, SK	1
Alexopoulos, P; Assimakopoulos, K; Economou, P; Gourzis, P; Grimmer, T; Ortner, M; Perneczky, R; Politis, A; Thierjung, N	1
Agosta, F; Arbizu, J; Boccardi, M; Bouwman, F; Drzezga, A; Nestor, P; Nobili, F; Walker, Z	1
Heiss, WD	1
Cho, SH; Jang, H; Kim, HJ; Kim, SE; Kim, SJ; Kim, Y; Lee, JS; Lockhart, SN; Na, DL; Park, S; Rabinovici, GD; Seo, SW; Seong, JK; Shin, JH	1
Eo, JS; Jeong, HG; Lee, ES; Lee, S; Suh, S; Youn, H	1
Anderson, T; Chen, L; Ge, JJ; Liu, FT; Tang, YL; Wang, J; Wu, L; Yu, H; Yu, WB; Zhao, J; Zuo, CT	1
Berg, D; Blum, D; la Fougère, C; Liepelt-Scarfone, I; Maetzler, W; Pilotto, A; Reimold, M	1
Brayne, C; Hyde, C; Kelly, S; Lafortune, L; Smailagic, N	1
Adel, M; Fossati, C; Gaidon, T; Guedj, E; Pan, X	1
Carnero-Pardo, C; Gómez-Río, M; Górriz, JM; Martínez-Lozano, MD; Ramírez, J; Sánchez-Vañó, R; Segovia, F; Sopena-Novales, P; Triviño-Ibáñez, E	1
Hu, B; Li, Y; Yao, Z; Zhang, H	1
Hsiao, IT; Hsu, JL; Huang, SY; Lin, KJ; Liu, HL; Wey, SP	1
Chu, JS; Han, CL; Liu, TH; Liu, YP; Ma, HZ; Meng, FG; Wang, KL; Xia, XT; Zang, YZ; Zhao, XB	1
Wang, Z; Zhang, J; Zhou, B; Zhou, W	1
Baran, TM; Lin, FV	1
Boxer, AL; Cho, H; Choi, JY; Gorno-Tempini, ML; Hansson, O; Janelidze, S; Jögi, J; Kramer, J; La Joie, R; Lyoo, CH; Mattsson, N; Miller, BL; Ohlsson, T; Ossenkoppele, R; Palmqvist, S; Rabinovici, GD; Ryu, YH; Santillo, A; Schöll, M; Smith, R; Strandberg, O; Tsai, R	1
Ahmad, S; Arnold, M; Baillie, R; Blach, C; Doraiswamy, PM; Han, X; Hankemeier, T; Jia, W; Kaddurah-Daouk, R; Kastenmüller, G; Kueider-Paisley, A; Louie, G; MahmoudianDehkordi, S; Nho, K; Risacher, SL; Saykin, AJ; Shaw, LM; Trojanowski, JQ; van Duijn, CM; Weiner, MW; Xie, G	1
Aboian, MS; Behr, SC; Copeland, TP; Ding, Y; Flavell, RR; Franc, BL; Hadley, D; Harnish, R; Hawkins, RA; Hernandez Pampaloni, M; Huang, SY; Jenkins, NW; Kawczynski, MG; Lituiev, D; Mari Aparici, C; Nardo, L; Seo, Y; Sohn, JH; Trivedi, H; Zalocusky, KA	1
Blazhenets, G; Frings, L; Meyer, PT; Rücker, G; Schiller, F; Sörensen, A	1
Arbizu, J; Boada, M; Martínez-Lage, P; Monleón, I; Munuera, J; Pérez-Grijalba, V; Pesini, P; Romero, J; Ruiz, A; San-José, I; Sarasa, L; Sarasa, M; Tárraga, L	1
Babic Perhoc, A; Bagaric, R; Farkas, V; Grünblatt, E; Knezovic, A; Osmanovic Barilar, J; Riederer, P; Salkovic-Petrisic, M; Svarc, A	1
Boellaard, R; De Deyn, PP; de Jong, BM; Dierckx, RAJO; Peretti, DE; Reesink, FE; Vállez García, D; van der Goot, T	1
Gillard, JH; Manavaki, R; O'Brien, JT; Priest, AN; Sajjadi, SA; Sheikh-Bahaei, N	1
Benzinger, TLS; Chen, X; Leal, JP; Liu, M; Paranjpe, I; Paranjpe, MD; Pomper, MG; Wang, R; Wong, DF; Zhou, Y	1
Choi, H; Ha, S; Kang, H; Lee, DS; Lee, H	1
Andreasson, U; Blennow, K; Cullen, NC; Mattsson, N; Zetterberg, H	1
Bernier, M; Bocti, C; Castellano, CA; Croteau, E; Cunnane, SC; Descoteaux, M; Fortier, M; Fulop, T; Langlois, F; Lepage, M; Roy, M; St-Pierre, V; Turcotte, ÉE; Vandenberghe, C; Whittingstall, K	1
Bunai, T; Kakimoto, A; Ouchi, Y; Terada, T; Yoshikawa, E	1
Aston, JAD; Benedet, AL; Chamoun, M; Cuello, AC; Gauthier, S; Hwang, H; Kang, MS; Mathotaarachchi, S; Misic, B; Mohaddes, S; Parent, MJ; Park, AY; Pascoal, TA; Rosa-Neto, P; Shin, M; Soucy, JP; Therriault, J	1
Blennow, K; Jack, C; Kern, S; Knopman, DS; Kremers, WK; Machulda, MM; Mielke, MM; Petersen, RC; Skoog, I; Syrjanen, JA; Vemuri, P; Zetterberg, H	1
Chiba, Y; Fujishiro, H; Iseki, E; Kasanuki, K; Sato, K	1
Iaccarino, L; Perani, D; Sala, A	1
Chen, Z; Han, X; Kuang, L; Xing, J; Xiong, F; Zhao, D	1
Chen, KL; Cui, M; Dong, Q; Guo, Y; Huang, YY; Li, JQ; Ou, YN; Tan, L; Xu, W; Yu, JT	1
Bastianello, M; Biafore, F; Depetris, TS; Peralta, C	1
Altomare, D; Barkhof, F; Caroli, A; Carter, SF; Choo, ILH; Drzezga, A; Ferrari, C; Frisoni, GB; Galluzzi, S; Grimmer, T; Nordberg, A; Ossenkoppele, R; Prestia, A; Redolfi, A; Scheltens, P; Schöll, M; Teunissen, CE; Van Berckel, B; van der Flier, WM; Wall, A	1
Alavi, A; Khosravi, M; Newberg, AB; Peter, J; Serruya, M; Shamchi, SP; Werner, TJ; Wintering, NA	1
Harbishettar, V; Mangalore, S; Mukku, SSR; Nagaraj, C; Sivakumar, PT; Varghese, M	1
Berg, D; Blum, D; Gasser, T; la Fougère, C; Liepelt-Scarfone, I; Reimold, M	1
Ahmad, S; Arnold, M; Baillie, R; Blach, C; Doraiswamy, PM; Han, X; Kaddurah-Daouk, R; Kastenmüller, G; Kueider-Paisley, A; Louie, G; MahmoudianDehkordi, S; Nho, K; Risacher, SL; Saykin, AJ; Shaw, LM; Trojanowski, JQ; van Duijn, C; Weiner, MW	1
Aso, Y; Eguchi, A; Hori, D; Ishibashi, M; Jikumaru, M; Kimura, N; Matsubara, E; Nakamichi, A; Sasaki, Y; Shimomura, T; Sumi, K; Uesugi, S; Yabuuchi, K	1
Andrews, RD; Matthews, DC; Mosconi, L	1
Chuang, WL; Hsiao, IT; Hsieh, CJ; Hsu, WC; Huang, CC; Huang, KL; Kung, MP; Kuo, HC; Lin, KJ; Wai, YY; Wey, SP; Yen, TC	1
Blum, K; Braverman, ER; Damle, UJ; Dushaj, K; Kerner, M; Oscar-Berman, M	1
Carreras, JL; Cruz, I; de Villoria, JG; Desco, M; García-Vázquez, V; Lacalle-Aurioles, M; Martino, ME; Navarro, E; Olazarán, J	1
Alexopoulos, P; Bujo, H; Drzezga, A; Förster, S; Grimmer, T; Guo, LH; Jiang, M; Kurz, A; Perneczky, R	1
Chew, J; Silverman, DH	1
Arbizu, J; García-Granero, M; Gómez-Isla, MT; Lamet, I; Martí-Climent, JM; Martínez-Lage, P; Pastor, P; Peñuelas, I; Prieto, E; Richter, JA; Riverol, M; Weiner, MW	1
Hatashita, S; Yamasaki, H	1
Brück, A; Helenius, H; Helin, S; Koikkalainen, J; Koivunen, J; Någren, K; Parkkola, R; Rinne, JO; Scheinin, NM; Viitanen, M; Virta, JR	1
Anzai, Y; Cross, DJ; Maravilla, KR; Martin, N; Minoshima, S; Peskind, ER; Petrie, EC; Richards, TL	1
Cappa, SF; Florea, I; Garibotto, V; Marcone, A; Moresco, R; Panzacchi, A; Perani, D; Rinne, J; Tettamanti, M; Virta, JR	1
Claassen, D; Ding, Z; Kang, H; Mishra, A; Riddle, WR; Rogers, B; Shokouhi, S	1
Martínez-Montes, E; Melie-Garcia, L; Sanabria-Diaz, G	1
Buus, S; Hansen, LB; Schafer-Nielsen, C	1
Arai, H; Asada, T; Ikari, Y; Ishii, K; Ito, K; Iwatsubo, T; Kato, T; Nishio, T; Senda, M; Silverman, DH; Sugishita, M; Yamane, T	1
Case, M; Hake, A; Hochstetler, H; Schuh, K; Sun, J; Trzepacz, PT; Witte, MM; Yu, P	1
Cabral, C; Silveira, M	1
Accardo, J; Arnaldi, D; Bossert, I; Brugnolo, A; De Carli, F; Dessi, B; Famà, F; Ferrara, M; Girtler, N; Morbelli, S; Nobili, F; Picco, A; Rodriguez, G; Sambuceti, G	1
Amariglio, RE; Becker, JA; Donovan, NJ; Gidicsin, CM; Johnson, KA; Lorius, N; Marshall, GA; Maye, J; Pepin, LC; Rentz, DM; Sperling, RA	1
Bartenstein, P; Brendel, M; Ewers, M; Rizk-Jackson, A; Rominger, A; Schuff, N; Weiner, MW	1
Arnaldi, D; Baglioni, M; Bastiani, P; Bossert, I; Brugnolo, A; Cecchetti, R; Dottorini, ME; Ferrara, M; Fiorucci, G; Mecocci, P; Morbelli, S; Nobili, F; Picco, A; Polidori, MC	1
Duong, TQ; Yu, F; Zhou, Y	1
Arai, A; Arai, H; Furukawa, K; Furumoto, S; Iwata, R; Kaneta, T; Kudo, Y; Okamura, N; Takahashi, S; Takanami, K; Tashiro, M; Yanai, K	1
Anton-Rodriguez, JM; Burns, A; Carter, SF; Embleton, KV; Herholz, K; Ralph, MA	1
Arnold, SE; Chen, K; Da, X; Davatzikos, C; Jack, C; Jagust, W; Reiman, EM; Shaw, LM; Toledo, JB; Trojanowski, JQ; Weiner, MW; Wolk, DA	1
Conejero-Goldberg, C; Davies, P; Goldberg, TE; Gomar, JJ	1
Bladowska, J; Leszek, J; Macioszek, A; Noga, L; Sasiadek, M; Szewczyk, P; Trypka, E; Wojtynska, R; Zimny, A	1
Boeve, BF; Gunter, JL; Jack, CR; Kantarci, K; Knopman, DS; Lowe, VJ; Lundt, ES; Mielke, MM; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ	1
Aprahamian, I; Buchpiguel, CA; Coutinho, AM; Diniz, BS; Forlenza, OV; Gattaz, WF; Mendes, LL; Prando, S	1
Bedell, BJ; Carbonell, F; Charil, A; Evans, AC; Zijdenbos, AP	2
Ewers, M; Grothe, MJ; Kljajevic, V; Teipel, S	1
Cohen, AD; Klunk, WE	1
Alexopoulos, P; Drzezga, A; Fellgiebel, A; Förster, S; Gray, K; Grimmer, T; Haller, B; Klupp, E; Kriett, L; Kurz, A; Laskaris, N; Perneczky, R; Yakushev, I	1
Becker, JA; Johnson, KA; Locascio, JJ; Lorius, N; Marshall, GA; Pepin, LC; Philiossaint, M; Rentz, DM; Roy, K; Sperling, RA	1
Ishibashi, K; Ishii, K; Ishiwata, K; Miura, Y; Oda, K	1
An, YS; Lee, SJ; Lim, TS; Moon, SY	1
Arbizu, J; Clavero, P; García-Eulate, R; García-García, D; Gasca-Salas, C; González-Redondo, R; Obeso, JA; Rodríguez-Oroz, MC; Zubieta, JL	1
Ashburner, J; Caroli, A; Castiglioni, I; Cerami, C; Della Rosa, PA; Frisoni, G; Friston, K; Gallivanone, F; Gilardi, MC; Perani, D; Prestia, A	1
Boutoleau-Bretonnière, C; Camus, V; Delrieu, J; Desmidt, T; Lebouvier, T; Mullin, E; Payoux, P; Sourdet, S; Vellas, B	1
Benetos, A; Joly, L; Karcher, G; Marie, PY; Poussier, S; Van Der Gucht, A; Verger, A; Watfa, G; Yagdigul, Y	1
Bertens, D; Knol, DL; Scheltens, P; Visser, PJ	1
Aguera, E; Bernabei, R; Bocchetta, M; Bullock, R; Ceccaldi, M; Dartigues, JF; de Mendonça, A; Didic, M; Eriksdotter, M; Félician, O; Frisoni, GB; Frölich, L; Galluzzi, S; Gertz, HJ; Hallikainen, M; Hasselbalch, SG; Hausner, L; Heuser, I; Jessen, F; Jones, RW; Kehoe, PG; Kurz, A; Lawlor, B; Lleo, A; Martinez-Lage, P; Mecocci, P; Mehrabian, S; Monsch, A; Nobili, F; Nordberg, A; Orgogozo, JM; Pasquier, F; Peters, O; Rikkert, MO; Salmon, E; Sánchez-Castellano, C; Santana, I; Sarazin, M; Traykov, L; Tsolaki, M; Visser, PJ; Wallin, ÅK; Wilcock, G; Wilkinson, D; Wolf, H; Yener, G; Zekry, D	1
Ahmed, I; Aman, Y; Brooks, DJ; Chetelat, G; Edison, P; Fan, Z; Landeau, B; Ray Chaudhuri, K	1
Cheng, B; Jie, B; Shen, D; Zhang, D	1
Baxter, LC; Caselli, RJ; Chen, K; Gutman, B; Reiman, EM; Reschke, C; Shi, J; Stonnington, CM; Thompson, PM; Wang, Y	1
Chung, MK; Kang, H; Lee, DS; Lee, H	1
Aarsland, D; Auning, E; Bjørnerud, A; Fladby, T; Grambaite, R; Haram, A; Hessen, E; Hol, PK; Løvli Stav, A; Muftuler løndalen, A; Šaltytė Benth, J; Selnes, P	1
Arnaldi, D; Bossert, I; Bottoni, G; Brugnolo, A; Buschiazzo, A; De Carli, F; Didic, M; Drzezga, A; Frisoni, GB; Galluzzi, S; Guedj, E; Morbelli, S; Nobili, F; Ossenkoppele, R; Pagani, M; Perneczky, R; Picco, A; Sambuceti, G; van Berckel, BN	1
Atienza, M; Cantero, JL; Garcia-Solis, D; Gonzalez-Escamilla, G	1
Han, B; He, W; Li, G; Liu, D; Radua, J; Sun, Z	1
Brucher, N; Filleron, T; Mandegaran, R; Wagner, T	1
Dowling, NM; Gleason, CE; Jagust, WJ; Johnson, SC	1
Choi, EK; Chung, SW; Chung, YA; Oh, JK; Song, IU	1
Bailly, M; Camus, V; Gissot, V; Guilloteau, D; Hommet, C; Ribeiro, MJ; Vercouillie, J	1
Rodrigues, F; Silveira, M	1
Arahata, Y; Fujiwara, K; Fukuyama, H; Ikeda, M; Ishii, K; Ito, K; Kato, T; Maeda, K; Meguro, K; Mitsuyama, Y; Okumura, A; Ouchi, Y; Senda, M; Washimi, Y; Yamamoto, Y	1
Arnaldi, D; Brugnolo, A; Buschiazzo, A; Chincarini, A; De Carli, F; Didic, M; Drzezga, A; Ferrara, M; Frisoni, GB; Galluzzi, S; Guedj, E; Morbelli, S; Nobili, F; Öberg, J; Ossenkoppele, R; Pagani, M; Perneczky, R; Picco, A; Sambuceti, G; van Berckel, BN	1
Cappa, SF; Cerami, C; Della Rosa, PA; Magnani, G; Marcone, A; Perani, D; Santangelo, R	1
Hyde, C; Martin, S; Sachpekidis, C; Smailagic, N; Ukoumunne, O; Vacante, M	1
Bartenstein, P; Brendel, M; Delker, A; Pogarell, O; Rominger, A; Xiong, G	1
Brown, EE; Caravaggio, F; Chakravarty, MM; Chow, TW; Chung, JK; Gerretsen, P; Graff-Guerrero, A; Iwata, Y; Mulsant, BH; Nakajima, S; Plitman, E	1
Fujishiro, H; Fukase, Y; Iseki, E; Kasanuki, K; Kondo, D; Murayama, N; Ota, K; Sato, K; Tagaya, H	1
Brucki, SM; Buchpiguel, CA; Coutinho, AM; de Oliveira, MO; do Vale, PH; Duran, FL; Gualano, B; Nitrini, R; Ono, CR; Pinto, AL; Porto, FH; Prando, S; Spíndola, L	1
Amaro, E; Grinberg, LT; Grothe, MJ; Heinsen, H; Teipel, SJ	1
Diehl-Schmid, J; Drzezga, A; Förster, S; Grimmer, T; Meng, C; Mulej Bratec, S; Pasquini, L; Riedl, V; Scherr, M; Schwaiger, M; Shi, K; Sorg, C; Tahmasian, M; Yakushev, I	1
Arnold, SE; Avants, BB; Gee, JC; Kandel, BM; Wolk, DA	1
Kim, J; Lee, JM; Park, H; Seo, J; Son, SJ	1
Benso, F; Ciarmiello, A; Del Sette, M; Gaeta, MC	1
Koeppe, R; Nan, B; Shu, H	1
Kwak, K; Lee, JM; Yun, HJ	1
Arbizu, J; Chételat, G; Drezgza, A; Garibotto, V; Hesse, S; Lammertsma, AA; Law, I; Morbelli, S; Pagani, M; Pappata', S; Payoux, P; Van De Giessen, E	1
Chételat, G; de la Sayette, V; Desgranges, B; Egret, S; Eustache, F; Jonin, PY; Landeau, B; Mézenge, F; Mutlu, J; Perrotin, A; Tomadesso, C	1
Grothe, MJ; Krause, B; Kurth, J; Teipel, SJ	1
Fero, A; Jagust, WJ; Landau, SM; Schreiber, F; Schreiber, S	1
Jie, B; Shen, D; Ye, T; Zhang, D; Zu, C	1
Fukuyama, H; Ito, K; Oishi, N; Ota, K	2
Caminiti, SP; Cappa, SF; Cerami, C; Comi, G; Coppi, E; Falini, A; Ferrari, L; Gianolli, L; Iannaccone, S; Magnani, G; Passerini, G; Perani, D; Pinto, P; Santangelo, R	1
Brucki, SM; Buchpiguel, CA; Coutinho, AM; de Oliveira, MO; do Vale, PH; Duran, FL; Feitosa, EA; Gomes, HR; Nitrini, R; Ono, CR; Porto, FH; Prando, S; Spíndola, L	1
Boecker, H; Drzezga, AE; Götz, J; Granert, O; Häussermann, P; Kurz, A; Perneczky, R; van Eimeren, T	1
Barthel, H; Hoffmann, KT; Patt, M; Sabri, O; Schroeter, ML; Tiepolt, S	1
Johansson, J; Joutsa, J; Kemppainen, N; Någren, K; Parkkola, R; Rinne, JO; Rokka, J; Scheinin, NM	1
Altmann, A; Greicius, MD; Jagust, WJ; Landau, SM; Ng, B	1
Boeve, BF; Gunter, JL; Jack, CR; Jones, DT; Kantarci, K; Knopman, DS; Lowe, VJ; Lundt, ES; Machulda, MM; Mielke, MM; Petersen, RC; Roberts, RO; Senjem, ML; Vemuri, P; Weigand, SD; Wiste, HJ	1
Baek, H; Byun, MS; Choe, YM; Choi, HJ; Han, JY; Kim, HJ; Lee, DY; Lee, JH; Seo, EH; Sohn, BK; Woo, JI; Yi, D	1
Almkvist, O; Carter, SF; Graff, C; Långström, B; Nordberg, A; Rodriguez-Vieitez, E; Schöll, M; Thordardottir, S; Wall, A; Westman, E	1
Grothe, MJ; Teipel, S	1
Jagust, W; Schuff, N; Tosun, D; Weiner, MW	1
Chen, S; Jie, B; Liu, M; Shen, D; Zhang, D; Zu, C	1
Brenner, W; Buchert, R; Frings, L; Lange, C; Spies, L; Suppa, P	1
Alexopoulos, P; Drzezga, A; Förster, S; Förstl, H; Goldhardt, O; Grimmer, T; Kurz, A; Ortner, M; Sorg, C; Wutz, C	1
Bertolino, A; Dukart, J; Sambataro, F	1
Clavero, P; García-García, D; Gasca-Salas, C; Obeso, JA; Rodríguez-Oroz, MC	1
Barocco, F; Caffarra, P; Gardini, S; Ghetti, C; Guzzo, C; Marchi, M; Ruffini, L; Spallazzi, M; Spotti, A	1
Eustache, P; Nemmi, F; Pariente, J; Péran, P; Saint-Aubert, L	1
Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Ota, K; Sato, K; Suzuki, M	1
Balédent, O; Bouzerar, R; Chaarani, B; Daouk, J; Meyer, ME; Zmudka, J	1
Almkvist, O; Carter, SF; Chiotis, K; Långström, B; Leuzy, A; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Schöll, M; Wall, A	1
Andriuta, D; Devendeville, A; Godefroy, O; Meyer, ME; Moullart, V; Schraen, S	1
Chen, K; Guo, X; Li, R; Long, Z; Wu, X; Xu, L; Yao, L; Zhang, J	1
Ayakta, N; Baker, SL; Bettcher, BM; Cantwell, A; Gorno-Tempini, ML; Jagust, WJ; Janabi, M; Kramer, JH; Lazaris, A; Lockhart, SN; Miller, BL; Miller, ZA; O'Neil, JP; Ossenkoppele, R; Rabinovici, GD; Santos, M; Schöll, M; Schonhaut, DR; Vogel, J; Vossel, KA	1
Kodewitz, A; Lang, E; Lelandais, S; Tome, AM; Vigneron, V	1
Al-Baddai, S; Górriz, JM; Lang, EW; Neubauer, A; Puntonet, CG; Salas-Gonzalez, D; Tomé, AM; Vigneron, V	1
Bartenstein, P; Brendel, M; Därr, S; Delker, A; Högenauer, M; Rominger, A; Weiss, M	1
Ding, Z; Ge, J; Guo, S; Liu, F; Liu, Z; Tang, Y; Wang, J; Wang, Y; Wu, J; Wu, P; Zuo, C	1
Chiotis, K; Leuzy, A; Nordberg, A; Rodriguez-Vieitez, E; Saint-Aubert, L; Wall, A	1
Aisen, PS; Donohue, MC; Insel, PS; Jagust, WJ; Mackin, RS; Mattsson, N; Nosheny, RL; Schöll, M; Tosun, D; Weiner, MW	1
Dricot, L; Hanseeuw, B; Ivanoiu, A; Lhommel, R; Quenon, L	1
Banzo, I; Bravo-Ferrer, Z; Carril, JM; De Arcocha-Torres, M; Jiménez-Bonilla, JF; Lavado-Pérez, C; Martínez-Rodríguez, I; Quirce, R; Rodríguez-Rodríguez, E; Sánchez-Juan, P	1
De Deyn, PP; Dierckx, RA; Sanchez, MA; Sanchez-Catasus, CA; Stormezand, GN; van Laar, PJ	1
Huang, E; Li, W; Risacher, SL; Saykin, AJ	1
Betensky, RA; Hanseeuw, BJ; Johnson, KA; Schultz, AP; Sperling, RA	1
Christianson, TJ; Geda, YE; Jack, CR; Knopman, DS; Krell-Roesch, J; Lowe, VJ; Machulda, MM; Mielke, MM; Petersen, RC; Pink, A; Roberts, RO; Ruider, H; Stokin, GB	1
Arnaldi, D; Bauckneht, M; Brugnolo, A; Buschiazzo, A; Chincarini, A; Giuliani, A; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Picco, A; Sambuceti, G	1
Chen, K; Guo, X; Hu, B; Wang, P; Wu, X; Yao, L; Ye, Q; Zhang, J	1
Apostolova, I; Bittner, D; Brenner, W; Buchert, R; Estrella, M; Fiebach, JB; Gövercin, M; Hampel, H; Haynes, JD; Lange, C; Mäurer, A; Mende, C; Peters, O; Prasad, V; Ritter, K; Roberts, A; Seybold, J; Spies, L; Steffen, I; Steinhagen-Thiessen, E; Suppa, P; Weygandt, M	1
Baek, H; Byun, MS; Choe, YM; Choi, HJ; Jeon, SY; Kim, HJ; Lee, DY; Lee, JH; Lee, Y; Woo, JI; Yi, D	1
Ahmed, S; Brindle, N; Chowdhury, FU; Jamieson, S; Motara, H; Olusoga, T; Patel, CN; Pillai, A; Russell, G; Scarsbrook, AF	1
Arai, H; Chiba, Y; Fujishiro, H; Hirayasu, Y; Iseki, E; Kasanuki, K; Kondo, D; Murayama, N; Ota, K; Sato, K	1
Lee, J; Silverman, DH; Torosyan, N	1
de Jong, BM; Dierckx, RA; Leenders, KL; Meles, SK; Teune, LK	1
Chung, YA; Song, IU; Yun, K	1
Bartrés-Faz, D; Dyrba, M; Grothe, MJ; Villeneuve, S; Wirth, M	1
Eliassen, CF; Fladby, T; Hessen, E; Reinvang, I; Selnes, P	1
Braskie, MN; Carmichael, OT; DeCarli, C; Maillard, P; Scott, JA; Thompson, PM; Tosun, D; Weiner, M	1
Ayakta, N; Jagust, WJ; La Joie, R; Lockhart, SN; Rabinovici, GD; Winer, JR	1
Cai, W; Feng, DD; Fulham, M; Lu, S; Xia, Y	1
Cabrera-Martín, MN; Carreras, JL; Matías-Guiu, J; Matías-Guiu, JA; Moreno-Ramos, T; Pérez-Pérez, A; Rognoni, T; Valles-Salgado, M	1
Alegret, M; Arbizu, J; Becker, JT; Boada, M; Buendía, M; Espinosa, A; Giménez, J; Hendrix, SB; Hernández, I; Ibarria, M; Lafuente, A; Landau, SM; Martínez-Lage, P; Munuera, J; Pesini, P; Pujadas, F; Ruiz, A; Ruiz, S; San José, I; Sarasa, M; Sotolongo-Grau, O; Tárraga, L; Tejero, MA; Valero, S	1
Accardo, J; Arnaldi, D; Bauckneht, M; Bongioanni, F; Chincarini, A; De Carli, F; Girtler, N; Giuliani, A; Jonsson, C; Morbelli, S; Nobili, F; Öberg, J; Pagani, M; Sambuceti, G	1
Foster, NL; Harvey, D; Jagust, WJ; Koeppe, RA; Landau, SM; Madison, CM; Reiman, EM; Weiner, MW	1
Almkvist, O; Engler, H; Forsberg, A; Kadir, A; Långström, B; Nordberg, A; Wall, A	1
Hajak, G; Hirschberger, B; Ibach, B; Klünemann, H; Männer, P; Marienhagen, J; Poljansky, S	1
Rowe, CC; Villemagne, VL	1
Herholz, K	1
Eikelenboom, P; Schmand, B; van Gool, WA	2
Arbuckle, M; Baker, LD; Callaghan, M; Claxton, A; Craft, S; Cross, D; Gerton, B; Green, PS; Leverenz, J; Minoshima, S; Montine, TJ; Plymate, SR; Tsai, E; Watson, GS	1
Bartenstein, P; Buchholz, HG; Buerger, K; Buschert, VC; Drzezga, A; Förster, S; Friese, U; Hampel, H; Teipel, SJ	1
Blomquist, G; Engler, H; Forsberg, A; Långström, B; Nordberg, A	1
Almkvist, O; Carter, SF; Engler, H; Långström, B; Nordberg, A; Schöll, M; Wall, A	1
Ding, Y; Feng, J; Guo, Y; Han, D; Tan, X; Zhang, S	1
Brooks, DJ; Koikkalainen, J; Lötjönen, J; Lundqvist, R; Soininen, H; Thurfjell, L; Vandenberghe, R; Waldemar, G	1
Barrio, JR; Bookheimer, SY; Ercoli, LM; Huang, SC; Kepe, V; Lavretsky, H; Miller, KJ; Siddarth, P; Silverman, DH; Small, GW	1
Duchesne, S; Mouiha, A	1
Jagust, WJ; Lo, RY	1
Narayan, VA; Thompson, PM; Wang, Y; Ye, J; Yuan, L	1
Bowman, FD; Derado, G; Zhang, L	1
Carter, RE; Claassen, DO; Lehman, VT; Lowe, V; Murphy, RC; Peller, PJ; Petersen, RC	1
Arbizu, J; Clavero, P; Garcia-Garcia, D; Gasca Salas, C; Gonzalez-Redondo, R; Lamet, I; Obeso, JA; Rodriguez-Oroz, MC	1
Almkvist, O; Choo, IH; Ni, R; Nordberg, A; Schöll, M; Wall, A	1
Amicucci, G; Bocchio-Chiavetto, L; Bonetti, M; Bonvicini, C; Cotelli, M; Frisoni, GB; Galluzzi, S; Geroldi, C; Ghidoni, R; Paghera, B; Zanetti, O	1
Aisen, PS; Jagust, WJ; Joshi, AD; Koeppe, RA; Landau, SM; Mintun, MA; Petersen, RC; Weiner, MW	1
Dauar, MT; Fonov, V; Gauthier, S; Jia, J; Leuzy, A; Mohades, S; Rosa-Neto, P; Rowley, J; Shin, M; Wu, L	1
Choe, YM; Lee, DS; Lee, DY; Lee, JM; Park, JS; Seo, EH; Sohn, BK; Woo, JI	1
Coello, C; Fladby, T; Gjerstad, L; Selnes, P; Skretting, A; Willoch, F	1
Fujishiro, H; Isek, E; Manabe, Y; Murayama, N; Ota, K; Sato, K; Tagaya, H	1

Reviews

19 review(s) available for fluorodeoxyglucose f18 and Cognitive Dysfunction

Article	Year
Positron Emission Tomography-Based Assessment of Cognitive Impairment and Dementias, Critical Role of Fluorodeoxyglucose in such Settings. PET clinics, 2022, Volume: 17, Issue:3 Topics: Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals	2022
Predicting cognitive decline in older people by structural and molecular imaging. Current opinion in neurology, 2023, 08-01, Volume: 36, Issue:4 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Positron-Emission Tomography; Prognosis; tau Proteins	2023
Optimizing Use of Neuroimaging Tools in Evaluation of Prodromal Alzheimer's Disease and Related Disorders. Journal of Alzheimer's disease : JAD, 2020, Volume: 77, Issue:3 Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Prodromal Symptoms	2020
Clinical validity of brain fluorodeoxyglucose positron emission tomography as a biomarker for Alzheimer's disease in the context of a structured 5-phase development framework. Neurobiology of aging, 2017, Volume: 52 Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results	2017
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:12 Topics: Cognitive Dysfunction; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Parkinsonian Disorders; Radiopharmaceuticals	2017
Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease. Translational research : the journal of laboratory and clinical medicine, 2018, Volume: 194 Topics: Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Machine Learning; Magnetic Resonance Imaging; Multimodal Imaging; Positron-Emission Tomography; Prognosis	2018
Clinical utility of FDG-PET for the clinical diagnosis in MCI. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:9 Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography	2018
The Additional Value of PET in the Assessment of Cerebral Small Vessel Disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2018, Volume: 59, Issue:11 Topics: Amyloidogenic Proteins; Cerebral Small Vessel Diseases; Cognitive Dysfunction; Dementia, Vascular; Diagnosis, Differential; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Molecular Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Synaptic Transmission; tau Proteins	2018
18F-FDG PET for Prediction of Conversion to Alzheimer's Disease Dementia in People with Mild Cognitive Impairment: An Updated Systematic Review of Test Accuracy. Journal of Alzheimer's disease : JAD, 2018, Volume: 64, Issue:4 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Neuropsychological Tests; Positron-Emission Tomography	2018
Recent Advancement and Clinical Implications of 18FDG-PET in Parkinson's Disease, Atypical Parkinsonisms, and Other Movement Disorders. Current neurology and neuroscience reports, 2019, 06-29, Volume: 19, Issue:8 Topics: Apathy; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Huntington Disease; Male; Movement Disorders; Parkinson Disease; Parkinsonian Disorders; Positron-Emission Tomography; REM Sleep Behavior Disorder; Tomography, Emission-Computed, Single-Photon	2019
Early detection of Alzheimer's disease using PiB and FDG PET. Neurobiology of disease, 2014, Volume: 72 Pt A Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Thiazoles	2014
Meta-analytic comparison between PIB-PET and FDG-PET results in Alzheimer's disease and MCI. Cell biochemistry and biophysics, 2015, Volume: 71, Issue:1 Topics: Alzheimer Disease; Aniline Compounds; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Thiazoles	2015
¹⁸F-FDG PET for the early diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI). The Cochrane database of systematic reviews, 2015, Jan-28, Volume: 1 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2015
A Cochrane review on brain [¹⁸F]FDG PET in dementia: limitations and future perspectives. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:10 Topics: Brain; Cognitive Dysfunction; Dementia; Evidence-Based Medicine; Female; Fluorodeoxyglucose F18; Forecasting; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2015
FDG-PET for Prediction of AD Dementia in Mild Cognitive Impairment. A Review of the State of the Art with Particular Emphasis on the Comparison with Other Neuroimaging Modalities (MRI and Perfusion SPECT). Current Alzheimer research, 2017, Volume: 14, Issue:2 Topics: Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon	2017
Metabolic Imaging in Parkinson Disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:1 Topics: Biomarkers; Brain; Brain Mapping; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Image Interpretation, Computer-Assisted; Molecular Imaging; Parkinson Disease; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2017
Amyloid imaging. International psychogeriatrics, 2011, Volume: 23 Suppl 2 Topics: Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Molecular Imaging; Neuroimaging; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon	2011
Perfusion SPECT and FDG-PET. International psychogeriatrics, 2011, Volume: 23 Suppl 2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon	2011
Diagnostic accuracy of 18 F-FDG and 11 C-PIB-PET for prediction of short-term conversion to Alzheimer's disease in subjects with mild cognitive impairment. International journal of clinical practice, 2012, Volume: 66, Issue:2 Topics: Aged; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Clinical Trials as Topic; Cognitive Dysfunction; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thiazoles	2012

Trials

21 trial(s) available for fluorodeoxyglucose f18 and Cognitive Dysfunction

Article	Year
Brain FDG PET for Short- to Medium-Term Prediction of Further Cognitive Decline and Need for Assisted Living in Acutely Hospitalized Geriatric Patients With Newly Detected Clinically Uncertain Cognitive Impairment. Clinical nuclear medicine, 2022, Feb-01, Volume: 47, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Uncertainty	2022
Early-Phase 18F-Florbetaben PET as an Alternative Modality for 18F-FDG PET. Clinical nuclear medicine, 2020, Volume: 45, Issue:1 Topics: Aged; Amyloid; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Neuroimaging; Positron-Emission Tomography; Prospective Studies; Stilbenes; Time Factors	2020
Predictive Value of Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020, Volume: 61, Issue:4 Topics: Aged; Alzheimer Disease; Aniline Compounds; Cognitive Dysfunction; Diagnosis, Differential; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Predictive Value of Tests	2020
Benfotiamine and Cognitive Decline in Alzheimer's Disease: Results of a Randomized Placebo-Controlled Phase IIa Clinical Trial. Journal of Alzheimer's disease : JAD, 2020, Volume: 78, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Apolipoprotein E4; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glycation End Products, Advanced; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thiamine; Treatment Outcome	2020
Disrupted metabolic connectivity in dopaminergic and cholinergic networks at different stages of dementia from Scientific reports, 2021, 03-08, Volume: 11, Issue:1 Topics: Aged; Aged, 80 and over; alpha-Synuclein; Alzheimer Disease; Cholinergic Agents; Cognitive Dysfunction; Dopamine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Positron-Emission Tomography	2021
A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech. Nature communications, 2021, 06-08, Volume: 12, Issue:1 Topics: Aged; Aged, 80 and over; Anisotropy; Apraxias; Cognitive Dysfunction; Diffusion Tensor Imaging; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Neurobiology; Neuroimaging; Neurons; Pathology, Molecular; Positron-Emission Tomography; Speech; tau Proteins	2021
Cognitive and imaging markers in non-demented subjects attending a memory clinic: study design and baseline findings of the MEMENTO cohort. Alzheimer's research & therapy, 2017, Aug-29, Volume: 9, Issue:1 Topics: Aged; Brain; Cognitive Dysfunction; Diagnostic Self Evaluation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; France; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroimaging; Neuropsychological Tests; Organ Size; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Research Design; Spinal Puncture	2017
Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data. NeuroImage. Clinical, 2019, Volume: 21 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prognosis	2019
Longitudinal progression of cognitive decline correlates with changes in the spatial pattern of brain 18F-FDG PET. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:9 Topics: Aged; Aged, 80 and over; Aging; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Spatio-Temporal Analysis	2013
Metabolic correlates of Rey auditory verbal learning test in elderly subjects with memory complaints. Journal of Alzheimer's disease : JAD, 2014, Volume: 39, Issue:1 Topics: Aged; Aged, 80 and over; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Frontal Lobe; Glucose; Gyrus Cinguli; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Mental Recall; Middle Aged; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Verbal Learning	2014
Long-term lithium treatment reduces glucose metabolism in the cerebellum and hippocampus of nondemented older adults: an [¹⁸F]FDG-PET study. ACS chemical neuroscience, 2014, Jun-18, Volume: 5, Issue:6 Topics: Aged; Brain Mapping; Cerebellum; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Lithium Carbonate; Male; Positron-Emission Tomography; Psychotropic Drugs; Radiopharmaceuticals	2014
Complementarity of visual and voxel-based FDG-PET analysis to detect MCI-like hypometabolic pattern in elderly patients with hypertension and isolated memory complaints. Acta radiologica (Stockholm, Sweden : 1987), 2015, Volume: 56, Issue:8 Topics: Aged; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Humans; Hypertension; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Memory Disorders; Middle Aged; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2015
The lower hippocampus global connectivity, the higher its local metabolism in Alzheimer disease. Neurology, 2015, May-12, Volume: 84, Issue:19 Topics: Alzheimer Disease; Cognitive Dysfunction; Connectome; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Nerve Net; Parietal Lobe; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2015
Combination of Structural MRI and FDG-PET of the Brain Improves Diagnostic Accuracy in Newly Manifested Cognitive Impairment in Geriatric Inpatients. Journal of Alzheimer's disease : JAD, 2016, 10-18, Volume: 54, Issue:4 Topics: Aged; Aged, 80 and over; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Geriatric Assessment; Health Services for the Aged; Humans; Inpatients; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Prospective Studies	2016
Examining the impact of grape consumption on brain metabolism and cognitive function in patients with mild decline in cognition: A double-blinded placebo controlled pilot study. Experimental gerontology, 2017, Volume: 87, Issue:Pt A Topics: Aged; Aged, 80 and over; California; Cerebral Cortex; Cognition; Cognitive Dysfunction; Dementia; Double-Blind Method; Female; Fluorodeoxyglucose F18; Fruit; Humans; Male; Neuropsychological Tests; Phytotherapy; Pilot Projects; Plant Preparations; Positron-Emission Tomography; Prospective Studies; Vitis	2017
Changes in cerebral glucose metabolism after 3 weeks of noninvasive electrical stimulation of mild cognitive impairment patients. Alzheimer's research & therapy, 2016, 12-01, Volume: 8, Issue:1 Topics: Aged; Aged, 80 and over; Cognitive Dysfunction; Double-Blind Method; Electroencephalography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Male; Mental Status Schedule; Neuropsychological Tests; Positron-Emission Tomography; Prefrontal Cortex; Transcranial Direct Current Stimulation	2016
Associations between cognitive, functional, and FDG-PET measures of decline in AD and MCI. Neurobiology of aging, 2011, Volume: 32, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Blood Glucose; Cognitive Dysfunction; Disability Evaluation; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Severity of Illness Index	2011
Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Archives of neurology, 2012, Volume: 69, Issue:1 Topics: Administration, Intranasal; Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hospitals, Veterans; Humans; Hypoglycemic Agents; Immunoassay; Insulin; Least-Squares Analysis; Male; Neuropsychological Tests; Peptide Fragments; Pilot Projects; Positron-Emission Tomography; Psychiatric Status Rating Scales; Spinal Puncture; tau Proteins	2012
Effects of a 6-month cognitive intervention on brain metabolism in patients with amnestic MCI and mild Alzheimer's disease. Journal of Alzheimer's disease : JAD, 2011, Volume: 26 Suppl 3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Brain Mapping; Cerebral Cortex; Cognitive Behavioral Therapy; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Treatment Outcome	2011
Visual assessment versus quantitative three-dimensional stereotactic surface projection fluorodeoxyglucose positron emission tomography for detection of mild cognitive impairment and Alzheimer disease. Clinical nuclear medicine, 2012, Volume: 37, Issue:8 Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Demography; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Male; Positron-Emission Tomography; Reference Standards; ROC Curve; Stereotaxic Techniques	2012
Dissociation between brain amyloid deposition and metabolism in early mild cognitive impairment. PloS one, 2012, Volume: 7, Issue:10 Topics: Aged; Aged, 80 and over; Amyloid; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography	2012

Other Studies

347 other study(ies) available for fluorodeoxyglucose f18 and Cognitive Dysfunction

Article	Year
The effects of cerebral amyloidopathy on regional glucose metabolism in older adults with depression and mild cognitive impairment while performing memory tasks. The European journal of neuroscience, 2021, Volume: 54, Issue:7 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Depression; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography	2021
Prediction of post-stroke cognitive impairment using brain FDG PET: deep learning-based approach. European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:4 Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Quality of Life; Tomography, X-Ray Computed	2022
Glucose hypometabolism in the Auditory Pathway in Age Related Hearing Loss in the ADNI cohort. NeuroImage. Clinical, 2021, Volume: 32 Topics: Alzheimer Disease; Auditory Pathways; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Genome-Wide Association Study; Glucose; Humans; Neuroimaging; Positron-Emission Tomography	2021
Added value of semiquantitative analysis of brain FDG-PET for the differentiation between MCI-Lewy bodies and MCI due to Alzheimer's disease. European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:4 Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography; Reproducibility of Results	2022
Relationship between Cerebrospinal Fluid Matrix Metalloproteinases Levels and Brain Amyloid Deposition in Mild Cognitive Impairment. Biomolecules, 2021, 10-11, Volume: 11, Issue:10 Topics: Aged; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Matrix Metalloproteinases; Regression Analysis; Thiazoles; Tissue Inhibitor of Metalloproteinases; White Matter	2021
Somatosensory dysfunction is masked by variable cognitive deficits across patients on the Alzheimer's disease spectrum. EBioMedicine, 2021, Volume: 73 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetoencephalography; Male; Middle Aged; Neuropsychological Tests; Positron Emission Tomography Computed Tomography; Somatosensory Cortex	2021
Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum. Journal of Alzheimer's disease : JAD, 2022, Volume: 85, Issue:1 Topics: Aged; Alzheimer Disease; Aminopyridines; Amnesia; Aniline Compounds; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Severity of Illness Index; tau Proteins; Thiazoles	2022
The Transition of Mild Cognitive Impairment Over Time: An AV45- and FDG-PET Study of Reversion and Conversion Phenomena. Current Alzheimer research, 2021, Volume: 18, Issue:9 Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Positron-Emission Tomography	2021
Neural correlates and predictors of subjective cognitive decline in patients with Parkinson's disease. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2022, Volume: 43, Issue:5 Topics: Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Retrospective Studies	2022
Association between Benton Visual Retention Test Scores and PET Imaging in Elderly Adults. Current Alzheimer research, 2021, Volume: 18, Issue:11 Topics: Adult; Aged; Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography	2021
Multimodal Classification of Alzheimer's Disease and Amnestic Mild Cognitive Impairment: Integrated 18F-FDG PET and DTI Study. Journal of Alzheimer's disease : JAD, 2022, Volume: 85, Issue:3 Topics: Aged; Alzheimer Disease; Amnesia; Biomarkers; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography	2022
Functional Neural Correlates of Semantic Fluency Task Performance in Mild Cognitive Impairment and Alzheimer's Disease: An FDG-PET Study. Journal of Alzheimer's disease : JAD, 2022, Volume: 85, Issue:4 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Semantics; Task Performance and Analysis	2022
Mitochondrial complex I abnormalities underlie neurodegeneration and cognitive decline in Alzheimer's disease. European journal of neurology, 2022, Volume: 29, Issue:5 Topics: Alzheimer Disease; Amyloidosis; Aniline Compounds; Atrophy; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography	2022
Using radiomics-based modelling to predict individual progression from mild cognitive impairment to Alzheimer's disease. European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:7 Topics: Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2022
Tracer-specific reference tissues selection improves detection of Human brain mapping, 2022, Volume: 43, Issue:7 Topics: Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Carbolines; Cognitive Dysfunction; Cross-Sectional Studies; Ethylene Glycols; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography	2022
Caspase-1 variant influencing CSF tau and FDG PET levels in non-demented elders from the ADNI cohort. BMC neurology, 2022, Feb-16, Volume: 22, Issue:1 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Caspase 1; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Neuroimaging; tau Proteins	2022
Disrupted coupling between salience network segregation and glucose metabolism is associated with cognitive decline in Alzheimer's disease - A simultaneous resting-state FDG-PET/fMRI study. NeuroImage. Clinical, 2022, Volume: 34 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging	2022
A Multi-Dimensional Comparison of Alzheimer's Disease Neurodegenerative Biomarkers. Journal of Alzheimer's disease : JAD, 2022, Volume: 87, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Cross-Sectional Studies; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; tau Proteins	2022
Cognitive decline and brainstem hypometabolism in long COVID: A case series. Brain and behavior, 2022, Volume: 12, Issue:4 Topics: Brain; Brain Stem; Cognitive Dysfunction; COVID-19; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Post-Acute COVID-19 Syndrome; Radiopharmaceuticals	2022
Development of prediction models for distinguishable cognitive trajectories in patients with amyloid positive mild cognitive impairment. Neurobiology of aging, 2022, Volume: 114 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Cognition; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2022
Validity of cingulate-precuneus-temporo-parietal hypometabolism for single-subject diagnosis of biomarker-proven atypical variants of Alzheimer's Disease. Journal of neurology, 2022, Volume: 269, Issue:8 Topics: Alzheimer Disease; Amyloidosis; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Parietal Lobe; Positron-Emission Tomography	2022
Brain Metabolism Related to Mild Cognitive Impairment and Phenoconversion in Patients With Isolated REM Sleep Behavior Disorder. Neurology, 2022, 06-14, Volume: 98, Issue:24 Topics: Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Prospective Studies; REM Sleep Behavior Disorder	2022
Glucose metabolism patterns: A potential index to characterize brain ageing and predict high conversion risk into cognitive impairment. GeroScience, 2022, Volume: 44, Issue:4 Topics: Aged; Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography	2022
Journal of neurology, 2022, Volume: 269, Issue:10 Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition; Cognitive Dysfunction; Continuous Positive Airway Pressure; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Sleep Apnea, Obstructive; tau Proteins	2022
Comparison of dynamic susceptibility contrast enhanced MR and FDG-PET brain studies in patients with Alzheimer's disease and amnestic mild cognitive impairment. Journal of translational medicine, 2022, 06-07, Volume: 20, Issue:1 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography	2022
Cognitive functioning, cerebrospinal fluid Alzheimer's disease biomarkers and cerebral glucose metabolism in late-onset epilepsy of unknown aetiology: A prospective study. The European journal of neuroscience, 2022, Volume: 56, Issue:9 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognition; Cognitive Dysfunction; Epilepsy; Fluorodeoxyglucose F18; Glucose; Humans; Peptide Fragments; Positron-Emission Tomography; Prospective Studies; tau Proteins	2022
Artificial Intelligence on FDG PET Images Identifies Mild Cognitive Impairment Patients with Neurodegenerative Disease. Journal of medical systems, 2022, Jun-17, Volume: 46, Issue:8 Topics: Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Neurodegenerative Diseases; Positron-Emission Tomography	2022
Amyloid, tau and metabolic PET correlates of cognition in early and late-onset Alzheimer's disease. Brain : a journal of neurology, 2022, 12-19, Volume: 145, Issue:12 Topics: Alzheimer Disease; Amyloid; Amyloidogenic Proteins; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; tau Proteins	2022
Identification and validation of Alzheimer's disease-related metabolic brain pattern in biomarker confirmed Alzheimer's dementia patients. Scientific reports, 2022, 07-11, Volume: 12, Issue:1 Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2022
Introducing a gatekeeping system for amyloid status assessment in mild cognitive impairment. European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:13 Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Apolipoprotein E4; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Gatekeeping; Humans; Positron-Emission Tomography; Reproducibility of Results	2022
Multi-scale discriminative regions analysis in FDG-PET imaging for early diagnosis of Alzheimer's disease. Journal of neural engineering, 2022, 08-09, Volume: 19, Issue:4 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2022
The Clinical Use of Alzheimer's Disease Biomarkers in Patients with Mild Cognitive Impairment: A European Alzheimer's Disease Consortium Survey. Journal of Alzheimer's disease : JAD, 2022, Volume: 89, Issue:2 Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Peptide Fragments; Positron-Emission Tomography; tau Proteins	2022
Rheumatoid Arthritis, Cognitive Impairment, and Neuroimaging Biomarkers: Results from the Mayo Clinic Study of Aging. Journal of Alzheimer's disease : JAD, 2022, Volume: 89, Issue:3 Topics: Aged; Aging; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Amyloidosis; Arthritis, Rheumatoid; Biomarkers; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography	2022
Discriminating Aging Cognitive Decline Spectrum Using PET and Magnetic Resonance Image Features. Journal of Alzheimer's disease : JAD, 2022, Volume: 89, Issue:3 Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Quality of Life	2022
Predicting cognitive decline in Parkinson's disease using FDG-PET-based supervised learning. The Journal of clinical investigation, 2022, 10-17, Volume: 132, Issue:20 Topics: Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Retrospective Studies; Supervised Machine Learning	2022
Monitoring Alzheimer's Disease Progression in Mild Cognitive Impairment Stage Using Machine Learning-Based FDG-PET Classification Methods. Journal of Alzheimer's disease : JAD, 2022, Volume: 89, Issue:4 Topics: Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Machine Learning; Prodromal Symptoms	2022
Biomarkers Related to Synaptic Dysfunction to Discriminate Alzheimer's Disease from Other Neurological Disorders. International journal of molecular sciences, 2022, Sep-16, Volume: 23, Issue:18 Topics: alpha-Synuclein; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Neurogranin; tau Proteins	2022
Deep multiview learning to identify imaging-driven subtypes in mild cognitive impairment. BMC bioinformatics, 2022, Sep-29, Volume: 23, Issue:Suppl 3 Topics: Alzheimer Disease; Arachnodactyly; Brain; Cognitive Dysfunction; Contracture; Fluorodeoxyglucose F18; Genetic Markers; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography	2022
Perivascular Space Predicts Brain Hypometabolism of Individuals with Underlying Amyloid Pathology. Journal of Alzheimer's disease : JAD, 2022, Volume: 90, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidogenic Proteins; Amyloidosis; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neuroimaging; Positron-Emission Tomography	2022
Alzheimer's Disease Prediction Algorithm Based on Group Convolution and a Joint Loss Function. Computational and mathematical methods in medicine, 2022, Volume: 2022 Topics: Algorithms; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2022
Deep learning signature of brain [ Scientific reports, 2022, 11-10, Volume: 12, Issue:1 Topics: Brain; Cognition; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; REM Sleep Behavior Disorder	2022
Multi-stage classification of Alzheimer's disease from Physical and engineering sciences in medicine, 2022, Volume: 45, Issue:4 Topics: Alzheimer Disease; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2022
Impact of Human Immunodeficiency Virus and Recreational Drugs on Cognitive Functions. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2023, 03-21, Volume: 76, Issue:6 Topics: Adult; Brain; Cognition; Cognitive Dysfunction; Fluorodeoxyglucose F18; HIV; HIV Infections; Humans; Illicit Drugs; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Prospective Studies	2023
Effect of APOE ε4 genotype on amyloid-β, glucose metabolism, and gray matter volume in cognitively normal individuals and amnestic mild cognitive impairment. European journal of neurology, 2023, Volume: 30, Issue:3 Topics: Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Follow-Up Studies; Genotype; Glucose; Gray Matter; Humans; Positron-Emission Tomography	2023
Academic radiology, 2023, Volume: 30, Issue:9 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Machine Learning; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; White Matter	2023
Brain imaging and behavior, 2023, Volume: 17, Issue:2 Topics: Adult; Algorithms; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Moyamoya Disease; Positron-Emission Tomography	2023
Vigorous, regular physical exercise may slow disease progression in Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2023, Volume: 19, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Disease Progression; Exercise; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography	2023
Does statin use affect amyloid beta deposition and brain metabolism? CNS neuroscience & therapeutics, 2023, Volume: 29, Issue:5 Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Positron-Emission Tomography	2023
Tau, β-Amyloid, and Glucose Metabolism Following Service-Related Traumatic Brain Injury in Vietnam War Veterans: The Australian Imaging Biomarkers and Lifestyle Study of Aging-Veterans Study (AIBL-VETS). Journal of neurotrauma, 2023, Volume: 40, Issue:11-12 Topics: Aged; Aging; Alzheimer Disease; Amyloid beta-Peptides; Australia; Biomarkers; Brain Injuries, Traumatic; Case-Control Studies; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Life Style; Male; Middle Aged; Positron-Emission Tomography; tau Proteins; Veterans; Vietnam	2023
Expert elicitation of risk factors for progression to dementia in individuals with mild cognitive impairment. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2023, Volume: 19, Issue:10 Topics: Alzheimer Disease; Atrophy; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans	2023
Brain FDG PET for visualizing the relation between impaired lung function and cognitive decline in lung cancer: a preliminary study. Nuclear medicine communications, 2023, Jun-01, Volume: 44, Issue:6 Topics: Aged; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Lung; Lung Neoplasms; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2023
Impaired self-awareness of cognitive deficits in Parkinson's disease relates to cingulate cortex dysfunction. Psychological medicine, 2023, Volume: 53, Issue:4 Topics: Brain; Cognition; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Parkinson Disease; Tomography, X-Ray Computed	2023
Metabolic Asymmetry Relates to Clinical Characteristics and Brain Network Abnormalities in Alzheimer's Disease. Journal of Alzheimer's disease : JAD, 2023, Volume: 93, Issue:4 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Metabolic Networks and Pathways; Positron-Emission Tomography	2023
Longitudinal changes in metabolic network activity in early Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2023, Volume: 19, Issue:9 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2023
Improving Alzheimer's Disease Diagnosis With Multi-Modal PET Embedding Features by a 3D Multi-Task MLP-Mixer Neural Network. IEEE journal of biomedical and health informatics, 2023, Volume: 27, Issue:8 Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neural Networks, Computer; Positron-Emission Tomography	2023
Characteristics of amnestic patients with hypometabolism patterns suggestive of Lewy body pathology. Brain : a journal of neurology, 2023, 11-02, Volume: 146, Issue:11 Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Fluorodeoxyglucose F18; Hallucinations; Humans; Lewy Bodies; Lewy Body Disease; Positron-Emission Tomography	2023
Comparison of Brain Amyloid Deposition and Cortical Glucose Metabolism Between Clinic- and Community-Based Cohort. Journal of Alzheimer's disease : JAD, 2023, Volume: 95, Issue:1 Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Positron-Emission Tomography; Prospective Studies	2023
Late-onset epilepsy with cognitive symptoms: Comparison of cognitive and imaging profiles with probable Alzheimer's disease. Epilepsy & behavior : E&B, 2023, Volume: 146 Topics: Alzheimer Disease; Cognition; Cognitive Dysfunction; Epilepsy; Fluorodeoxyglucose F18; Humans; Neuropsychological Tests; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Retrospective Studies; Seizures	2023
White matter hyperintensity volume modifies the association between CSF vascular inflammatory biomarkers and regional FDG-PET along the Alzheimer's disease continuum. Neurobiology of aging, 2023, Volume: 132 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; C-Reactive Protein; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Inflammation; Magnetic Resonance Imaging; Positron-Emission Tomography; Vascular Endothelial Growth Factor A; White Matter	2023
Deep learning based diagnosis of Alzheimer's disease using FDG-PET images. Neuroscience letters, 2023, 11-20, Volume: 817 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Neuroimaging; Positron-Emission Tomography	2023
Hybrid PET/MRI with Flutemetamol and FDG in Alzheimer's Disease Clinical Continuum. Current Alzheimer research, 2023, Volume: 20, Issue:7 Topics: Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography	2023
Altered Brain Glucose Metabolism Assessed by Neuroscience, 2019, 10-01, Volume: 417 Topics: Adult; Brain; CADASIL; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography	2019
Neuronal injury biomarkers for assessment of the individual cognitive reserve in clinically suspected Alzheimer's disease. NeuroImage. Clinical, 2019, Volume: 24 Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Cognitive Reserve; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; tau Proteins	2019
Alzheimer's & dementia : the journal of the Alzheimer's Association, 2019, Volume: 15, Issue:9 Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Cerebrovascular Circulation; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Severity of Illness Index	2019
Spatial distributions of cholinergic impairment and neuronal hypometabolism differ in MCI due to AD. NeuroImage. Clinical, 2019, Volume: 24 Topics: Acetates; Acetylcholinesterase; Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Piperidines; Positron-Emission Tomography; Radiopharmaceuticals	2019
Brain 18FDG-PET pattern in patients with alcohol-related cognitive impairment. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:2 Topics: Aged; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Tomography, X-Ray Computed	2020
Quantifying brain metabolism from FDG-PET images into a probability of Alzheimer's dementia score. Human brain mapping, 2020, Volume: 41, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals	2020
Association of striatal dopaminergic neuronal integrity with cognitive dysfunction and cerebral cortical metabolism in Parkinson's disease with mild cognitive impairment. Nuclear medicine communications, 2019, Volume: 40, Issue:12 Topics: Cerebral Cortex; Cognitive Dysfunction; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neostriatum; Neurons; Parkinson Disease; Positron Emission Tomography Computed Tomography; Retrospective Studies	2019
Multiple System Atrophy: Phenotypic spectrum approach coupled with brain 18-FDG PET. Parkinsonism & related disorders, 2019, Volume: 67 Topics: Accidental Falls; Aged; Basal Ganglia Diseases; Brain; Cerebellar Diseases; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Gait Disorders, Neurologic; Humans; Hypotension, Orthostatic; Laryngeal Diseases; Latent Class Analysis; Male; Middle Aged; Multiple System Atrophy; Muscular Atrophy, Spinal; Pharyngeal Diseases; Phenotype; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Retrospective Studies; Spinal Curvatures; Urinary Incontinence	2019
Reciprocal Incremental Value of 18F-FDG-PET and Cerebrospinal Fluid Biomarkers in Mild Cognitive Impairment Patients Suspected for Alzheimer's Disease and Inconclusive First Biomarker. Journal of Alzheimer's disease : JAD, 2019, Volume: 72, Issue:4 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; tau Proteins	2019
The accuracy of hippocampal volumetry and glucose metabolism for the diagnosis of patients with suspected Alzheimer's disease, using automatic quantitative clinical tools. Medicine, 2019, Volume: 98, Issue:45 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Early Diagnosis; Female; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiographic Image Interpretation, Computer-Assisted; Retrospective Studies; Sensitivity and Specificity	2019
ZTE MR-based attenuation correction in brain FDG-PET/MR: performance in patients with cognitive impairment. European radiology, 2020, Volume: 30, Issue:3 Topics: Adult; Aged; Aged, 80 and over; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography	2020
Cognitive signature of brain FDG PET based on deep learning: domain transfer from Alzheimer's disease to Parkinson's disease. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:2 Topics: Alzheimer Disease; Brain; Cognition; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography	2020
Plasma Aβ42/40 ratio alone or combined with FDG-PET can accurately predict amyloid-PET positivity: a cross-sectional analysis from the AB255 Study. Alzheimer's research & therapy, 2019, 12-01, Volume: 11, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Peptide Fragments; Positron-Emission Tomography	2019
Spatially Distributed Amyloid-β Reduces Glucose Metabolism in Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, 2020, Volume: 73, Issue:2 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Apolipoprotein E4; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Genotype; Glucose; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography	2020
Combined 18F-fluorodeoxyglucose positron emission tomography and event-related potentials study of the cognitive impairment mechanisms in Parkinson's disease. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2020, Volume: 72 Topics: Aged; Cognitive Dysfunction; Evoked Potentials; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Temporal Lobe	2020
Real-space navigation testing differentiates between amyloid-positive and -negative aMCI. Neurology, 2020, 02-25, Volume: 94, Issue:8 Topics: Aged; Amnesia; Amyloid; Case-Control Studies; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Hippocampus; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Spatial Navigation; Visual Perception	2020
Arterial spin labeling versus NeuroImage. Clinical, 2020, Volume: 25 Topics: Aged; Aged, 80 and over; Biomarkers; Cerebrovascular Circulation; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Spin Labels	2020
Brain metabolic connectome classify mild cognitive impairment into Alzheimer's dementia Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2019, Volume: 2019 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2019
Brain PET amyloid and neurodegeneration biomarkers in the context of the 2018 NIA-AA research framework: an individual approach exploring clinical-biomarker mismatches and sociodemographic parameters. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:11 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed	2020
Metabolic correlates of cognitive impairment in mesial temporal lobe epilepsy. Epilepsy & behavior : E&B, 2020, Volume: 105 Topics: Adolescent; Adult; Cerebral Cortex; Cognitive Dysfunction; Epilepsy, Temporal Lobe; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Nerve Net; Neuropsychological Tests; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe; Young Adult	2020
Neurocognitive dysfunction and brain FDG-PET/CT findings in HIV-infected hemophilia patients and HIV-infected non-hemophilia patients. PloS one, 2020, Volume: 15, Issue:3 Topics: Adult; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hemophilia A; HIV Infections; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence	2020
Metabolic lesion-deficit mapping of human cognition. Brain : a journal of neurology, 2020, 03-01, Volume: 143, Issue:3 Topics: Adult; Brain; Cognitive Dysfunction; Cross-Sectional Studies; Epilepsies, Partial; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Young Adult	2020
Comparison of T The Journal of neuropsychiatry and clinical neurosciences, 2020,Fall, Volume: 32, Issue:4 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Pilot Projects; Positron-Emission Tomography; Thiazoles	2020
Predicting MCI progression with FDG-PET and cognitive scores: a longitudinal study. BMC neurology, 2020, Apr-21, Volume: 20, Issue:1 Topics: Algorithms; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Mental Status and Dementia Tests; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity	2020
Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer's dementia. European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:12 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Tomography, X-Ray Computed	2020
CSF p-tau/Aβ European journal of nuclear medicine and molecular imaging, 2020, Volume: 47, Issue:13 Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Peptide Fragments; tau Proteins	2020
Evaluating 2-[ NeuroImage. Clinical, 2020, Volume: 27 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Tomography, Emission-Computed, Single-Photon	2020
Deep learning-guided joint attenuation and scatter correction in multitracer neuroimaging studies. Human brain mapping, 2020, Volume: 41, Issue:13 Topics: Adult; Aged; Aged, 80 and over; Aniline Compounds; Benzothiazoles; Carbolines; Cognitive Dysfunction; Deep Learning; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, X-Ray Computed; Young Adult	2020
The impact of atlas-based MR attenuation correction on the diagnosis of FDG-PET/MR for Alzheimer's diseases- A simulation study combining multi-center data and ADNI-data. PloS one, 2020, Volume: 15, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Computer Simulation; Datasets as Topic; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuroimaging; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2020
Association of Modifiable Lifestyle Factors With Cortical Amyloid Burden and Cerebral Glucose Metabolism in Older Adults With Mild Cognitive Impairment. JAMA network open, 2020, 06-01, Volume: 3, Issue:6 Topics: Aged; Aged, 80 and over; Amyloid; Cerebellum; Cerebral Cortex; Cognitive Dysfunction; Female; Fitness Trackers; Fluorodeoxyglucose F18; Glucose; Humans; Life Style; Male; Positron-Emission Tomography; Prospective Studies; Sleep; Speech; Walking	2020
Fascicle- and Glucose-Specific Deterioration in White Matter Energy Supply in Alzheimer's Disease. Journal of Alzheimer's disease : JAD, 2020, Volume: 76, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Diffusion Magnetic Resonance Imaging; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Gyrus Cinguli; Humans; Male; Middle Aged; White Matter	2020
Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet (London, England), 2020, 06-27, Volume: 395, Issue:10242 Topics: Adult; Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Down Syndrome; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Neurofilament Proteins; Positron-Emission Tomography; Prevalence; Spain; tau Proteins; United Kingdom	2020
Brain Regional Glucose Metabolism, Neuropsychiatric Symptoms, and the Risk of Incident Mild Cognitive Impairment: The Mayo Clinic Study of Aging. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2021, Volume: 29, Issue:2 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Prospective Studies	2021
Impact of Tracer Retention Levels on Visual Analysis of Cerebral [ Current radiopharmaceuticals, 2021, Volume: 14, Issue:1 Topics: Aged; Aniline Compounds; Brain; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Italy; Male; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Stilbenes	2021
Clinical impact of European journal of nuclear medicine and molecular imaging, 2021, Volume: 48, Issue:2 Topics: Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Memory; Positron-Emission Tomography	2021
Multi-View Separable Pyramid Network for AD Prediction at MCI Stage by IEEE transactions on medical imaging, 2021, Volume: 40, Issue:1 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2021
A Novel Metabolic Connectome Method to Predict Progression to Mild Cognitive Impairment. Behavioural neurology, 2020, Volume: 2020 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography	2020
Brain FDG PET for the Etiological Diagnosis of Clinically Uncertain Cognitive Impairment During Delirium in Remission. Journal of Alzheimer's disease : JAD, 2020, Volume: 77, Issue:4 Topics: Aged; Aged, 80 and over; Brain; Cognitive Dysfunction; Delirium; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prospective Studies; Remission Induction; Uncertainty	2020
FDG PET Data is Associated with Cognitive Performance in Patients from a Memory Clinic. Journal of Alzheimer's disease : JAD, 2020, Volume: 78, Issue:1 Topics: Aged; Aged, 80 and over; Cerebral Small Vessel Diseases; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Germany; Humans; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Retrospective Studies	2020
Relationship Between PET-Assessed Amyloid Burden and Visual and Verbal Episodic Memory Performance in Elderly Subjects. Journal of Alzheimer's disease : JAD, 2020, Volume: 78, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Memory, Episodic; Neuropsychological Tests; Positron-Emission Tomography; Thiazoles	2020
FDG-PET hypermetabolism is associated with higher tau-PET in mild cognitive impairment at low amyloid-PET levels. Alzheimer's research & therapy, 2020, 10-19, Volume: 12, Issue:1 Topics: Alzheimer Disease; Amyloid; Amyloid beta-Peptides; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; tau Proteins	2020
Principal-Component Analysis-Based Measures of PET Data Closely Reflect Neuropathologic Staging Schemes. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, 06-01, Volume: 62, Issue:6 Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Principal Component Analysis	2021
Impairment of Everyday Spatial Navigation Abilities in Mild Cognitive Impairment Is Weakly Associated with Reduced Grey Matter Volume in the Medial Part of the Entorhinal Cortex. Journal of Alzheimer's disease : JAD, 2020, Volume: 78, Issue:3 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Atrophy; Cognitive Dysfunction; Entorhinal Cortex; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Spatial Navigation	2020
Cortical hypometabolism associated with cognitive impairment of multiple system atrophy. Parkinsonism & related disorders, 2020, Volume: 81 Topics: Aged; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multiple System Atrophy; Positron-Emission Tomography; Radiopharmaceuticals	2020
Clinical impact of dual-tracer FDOPA and FDG PET/CT for the evaluation of patients with parkinsonian syndromes. Medicine, 2020, Nov-06, Volume: 99, Issue:45 Topics: Adult; Aged; Aged, 80 and over; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Parkinsonian Disorders; Patient Care Management; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Retrospective Studies	2020
Association of Cerebrospinal Fluid Adiponectin Levels With Cerebral Glucose Metabolism In Mild Cognitive Impairment: A Pilot Study. Current Alzheimer research, 2020, Volume: 17, Issue:12 Topics: Adiponectin; Aged; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Pilot Projects; Positron-Emission Tomography; Thiazoles	2020
Protective Factors Modulate the Risk of Beta Amyloid in Alzheimer's Disease. Behavioural neurology, 2020, Volume: 2020 Topics: Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Protective Factors	2020
Biomarker-based stability in limbic-predominant amnestic mild cognitive impairment. European journal of neurology, 2021, Volume: 28, Issue:4 Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Positron-Emission Tomography; Retrospective Studies	2021
The Differential Influence of Immune, Endocytotic, and Lipid Metabolism Genes on Amyloid Deposition and Neurodegeneration in Subjects at Risk of Alzheimer's Disease. Journal of Alzheimer's disease : JAD, 2021, Volume: 79, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Endocytosis; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Immunity; Linear Models; Lipid Metabolism; Male; Multifactorial Inheritance; Polymorphism, Single Nucleotide; Positron-Emission Tomography; Radiopharmaceuticals	2021
The interplay among education, brain metabolism, and cognitive impairment suggests a role of cognitive reserve in Amyotrophic Lateral Sclerosis. Neurobiology of aging, 2021, Volume: 98 Topics: Amyotrophic Lateral Sclerosis; Brain; Brain Damage, Chronic; Cognitive Dysfunction; Cognitive Reserve; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals	2021
Validation of the Alzheimer Disease Dementia Conversion-Related Pattern as an ATN Biomarker of Neurodegeneration. Neurology, 2021, 03-02, Volume: 96, Issue:9 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofilament Proteins; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Risk Assessment; tau Proteins	2021
Brain Metabolism and Microglia Activation in Mild Cognitive Impairment: A Combined [18F]FDG and [11C]-(R)-PK11195 PET Study. Journal of Alzheimer's disease : JAD, 2021, Volume: 80, Issue:1 Topics: Aged; Brain; Brain Mapping; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Isoquinolines; Macrophage Activation; Male; Mental Status and Dementia Tests; Microglia; Middle Aged; Positron-Emission Tomography; Psychomotor Performance; Radiopharmaceuticals	2021
Blinded Clinical Evaluation for Dementia of Alzheimer's Type Classification Using FDG-PET: A Comparison Between Feature-Engineered and Non-Feature-Engineered Machine Learning Methods. Journal of Alzheimer's disease : JAD, 2021, Volume: 80, Issue:2 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Humans; Machine Learning; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals	2021
A Comparison of Two Statistical Mapping Tools for Automated Brain FDG-PET Analysis in Predicting Conversion to Alzheimer's Disease in Subjects with Mild Cognitive Impairment. Current Alzheimer research, 2020, Volume: 17, Issue:13 Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Models, Statistical; Positron-Emission Tomography; Radiopharmaceuticals; Sweden	2020
Data-driven FDG-PET subtypes of Alzheimer's disease-related neurodegeneration. Alzheimer's research & therapy, 2021, 02-19, Volume: 13, Issue:1 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography	2021
Clinical Relevance of [ Molecules (Basel, Switzerland), 2021, Feb-26, Volume: 26, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; tau Proteins	2021
New Trajectory of Clinical and Biomarker Changes in Sporadic Alzheimer's Disease. Cerebral cortex (New York, N.Y. : 1991), 2021, 06-10, Volume: 31, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals	2021
Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2021, 07-01, Volume: 62, Issue:7 Topics: Adult; Aged; Chronic Disease; Cognitive Dysfunction; COVID-19; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neocortex; Positron Emission Tomography Computed Tomography; Recovery of Function	2021
Glucose metabolism in the right middle temporal gyrus could be a potential biomarker for subjective cognitive decline: a study of a Han population. Alzheimer's research & therapy, 2021, 04-07, Volume: 13, Issue:1 Topics: Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; Temporal Lobe	2021
F-18 ML-104 tau PET imaging in mild cognitive impairment. Nuclear medicine communications, 2021, Aug-01, Volume: 42, Issue:8 Topics: Aged; Alzheimer Disease; Amnesia; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography	2021
Functional Neural Correlates of the WAIS-IV Block Design Test in Older Adult with Mild Cognitive Impairment and Alzheimer's Disease. Neuroscience, 2021, 05-21, Volume: 463 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography	2021
Functional Role of the Cerebellum in Parkinson Disease: A PET Study. Neurology, 2021, 06-08, Volume: 96, Issue:23 Topics: Adult; Aged; Basal Ganglia; Behavioral Symptoms; Cerebellum; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nerve Net; Parkinson Disease; Positron-Emission Tomography; Principal Component Analysis; Thalamus	2021
Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. Journal of neurology, 2022, Volume: 269, Issue:1 Topics: Activities of Daily Living; Brain; Cognition; Cognitive Dysfunction; COVID-19; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Post-Acute COVID-19 Syndrome; SARS-CoV-2	2022
FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD. NeuroImage. Clinical, 2021, Volume: 31 Topics: Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Positron-Emission Tomography	2021
Mild cognitive impairment and abnormal brain metabolic expression in idiopathic REM sleep behavior disorder. Parkinsonism & related disorders, 2021, Volume: 90 Topics: Aged; Brain; Brain Diseases, Metabolic; Cognitive Dysfunction; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Memory; Middle Aged; Polysomnography; Positron-Emission Tomography; Radiopharmaceuticals; REM Sleep Behavior Disorder; Verbal Behavior	2021
A 3D deep learning model to predict the diagnosis of dementia with Lewy bodies, Alzheimer's disease, and mild cognitive impairment using brain 18F-FDG PET. European journal of nuclear medicine and molecular imaging, 2022, Volume: 49, Issue:2 Topics: Alzheimer Disease; Brain; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Lewy Body Disease; Neurodegenerative Diseases; Positron-Emission Tomography; Retrospective Studies	2022
Cortical hypometabolism reflects local atrophy and tau pathology in symptomatic Alzheimer's disease. Brain : a journal of neurology, 2022, 04-18, Volume: 145, Issue:2 Topics: Alzheimer Disease; Amyloid; Apolipoprotein E4; Atrophy; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Positron-Emission Tomography; tau Proteins	2022
Cerebral glucose metabolism and cognition in newly diagnosed Parkinson's disease: ICICLE-PD study. Journal of neurology, neurosurgery, and psychiatry, 2017, Volume: 88, Issue:4 Topics: Aged; Aged, 80 and over; Blood Glucose; Brain; Brain Mapping; Cognitive Dysfunction; Cohort Studies; England; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Mental Status Schedule; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Statistics as Topic	2017
Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology. JAMA neurology, 2017, 06-01, Volume: 74, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neurodegenerative Diseases; Parietal Lobe; Positron-Emission Tomography; Temporal Lobe	2017
Value of FDG-PET scans of non-demented patients in predicting rates of future cognitive and functional decline. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:8 Topics: Aged; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography	2017
Regional 18F-Fluorodeoxyglucose Hypometabolism is Associated with Higher Apathy Scores Over Time in Early Alzheimer Disease. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2017, Volume: 25, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apathy; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Longitudinal Studies; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Radiopharmaceuticals	2017
Longitudinal changes of tau PET imaging in relation to hypometabolism in prodromal and Alzheimer's disease dementia. Molecular psychiatry, 2018, Volume: 23, Issue:7 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Cognition; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; tau Proteins	2018
Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia. Brain : a journal of neurology, 2017, Jul-01, Volume: 140, Issue:7 Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Atrophy; Blood Pressure; Brain; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Neurons; Neuropsychological Tests; Positron-Emission Tomography; Spin Labels; Vascular Resistance; White Matter	2017
Anosognosia for memory deficits in mild cognitive impairment: Insight into the neural mechanism using functional and molecular imaging. NeuroImage. Clinical, 2017, Volume: 15 Topics: Aged; Aged, 80 and over; Agnosia; Awareness; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Molecular Imaging; Positron-Emission Tomography	2017
Early identification of MCI converting to AD: a FDG PET study. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:12 Topics: Alzheimer Disease; Case-Control Studies; Cognitive Dysfunction; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Support Vector Machine	2017
A Cross-Validation of FDG- and Amyloid-PET Biomarkers in Mild Cognitive Impairment for the Risk Prediction to Dementia due to Alzheimer's Disease in a Clinical Setting. Journal of Alzheimer's disease : JAD, 2017, Volume: 59, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Biomarkers; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Thiazoles	2017
Relationship Between Body Mass Index, ApoE4 Status, and PET-Based Amyloid and Neurodegeneration Markers in Amyloid-Positive Subjects with Normal Cognition or Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, 2018, Volume: 65, Issue:3 Topics: Adaptor Proteins, Signal Transducing; Aged; Amyloid; Aniline Compounds; Apolipoprotein E4; Body Mass Index; Brain; Cognition; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Heterozygote; Humans; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Repressor Proteins; Weight Loss; Zebrafish Proteins	2018
A cross-sectional comparison of brain glucose and ketone metabolism in cognitively healthy older adults, mild cognitive impairment and early Alzheimer's disease. Experimental gerontology, 2018, 07-01, Volume: 107 Topics: Acetoacetates; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Linear Models; Magnetic Resonance Imaging; Male; Positron-Emission Tomography	2018
Comparison of PASL, PCASL, and background-suppressed 3D PCASL in mild cognitive impairment. Human brain mapping, 2017, Volume: 38, Issue:10 Topics: Aged; Brain; Brain Mapping; Cognitive Dysfunction; Cohort Studies; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Mental Status Schedule; Positron-Emission Tomography; Radiopharmaceuticals	2017
Cerebral PET glucose hypometabolism in subjects with mild cognitive impairment and higher EEG high-alpha/low-alpha frequency power ratio. Neurobiology of aging, 2017, Volume: 58 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Electroencephalography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins	2017
Activation of brain glucose metabolism ameliorating cognitive impairment in APP/PS1 transgenic mice by electroacupuncture. Free radical biology & medicine, 2017, Volume: 112 Topics: Alzheimer Disease; Amyloid beta-Protein Precursor; Animals; Brain Mapping; Cerebral Cortex; Cognitive Dysfunction; DNA-Binding Proteins; Electroacupuncture; Energy Metabolism; Exploratory Behavior; Fluorodeoxyglucose F18; Gene Expression Regulation; Glial Fibrillary Acidic Protein; Glucose; Glucose Transporter Type 1; Glucose Transporter Type 3; Hippocampus; Humans; Mice; Mice, Transgenic; Nerve Tissue Proteins; Nuclear Proteins; Positron-Emission Tomography; Spatial Learning	2017
18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage. European journal of nuclear medicine and molecular imaging, 2017, Volume: 44, Issue:12 Topics: Alzheimer Disease; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Positron-Emission Tomography; Prognosis	2017
Tau positron emission tomography using [ Neurobiology of aging, 2017, Volume: 59 Topics: Aged; Alzheimer Disease; Aminopyridines; Amnesia; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Severity of Illness Index; tau Proteins	2017
Longer-Term Investigation of the Value of 18F-FDG-PET and Magnetic Resonance Imaging for Predicting the Conversion of Mild Cognitive Impairment to Alzheimer's Disease: A Multicenter Study. Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:3 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Multivariate Analysis; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity	2017
The Alzheimer's disease metabolic brain pattern in mild cognitive impairment. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:12 Topics: Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Positron-Emission Tomography; Radiopharmaceuticals	2017
Learning Metabolic Brain Networks in MCI and AD by Robustness and Leave-One-Out Analysis: An FDG-PET Study. American journal of Alzheimer's disease and other dementias, 2018, Volume: 33, Issue:1 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Learning; Male; Metabolic Networks and Pathways; Neuropsychological Tests; Positron-Emission Tomography	2018
Biomarkers in subtypes of mild cognitive impairment and subjective cognitive decline. Brain and behavior, 2017, Volume: 7, Issue:9 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; tau Proteins	2017
Effects of Tianmagouteng particles on brain cognitive function in spontaneously hypertensive rats with hyperactivity of liver-yang: A [F-18] FDG micro-PET imaging study. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2017, Volume: 95 Topics: Animals; Brain; Cognition; Cognitive Dysfunction; Drugs, Chinese Herbal; Fluorodeoxyglucose F18; Glucose; Hypertension; Liver; Male; Maze Learning; Positron-Emission Tomography; Random Allocation; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley	2017
Utility of Molecular and Structural Brain Imaging to Predict Progression from Mild Cognitive Impairment to Dementia. Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:3 Topics: Aged; Aged, 80 and over; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Magnetic Resonance Imaging; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Prognosis; Proportional Hazards Models; Radiopharmaceuticals; Thiazoles	2017
Multimodal Imaging in Rat Model Recapitulates Alzheimer's Disease Biomarkers Abnormalities. The Journal of neuroscience : the official journal of the Society for Neuroscience, 2017, 12-13, Volume: 37, Issue:50 Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloidosis; Animals; Animals, Genetically Modified; Biomarkers; Brain; Brain Chemistry; Cognitive Dysfunction; Disease Models, Animal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Magnetic Resonance Imaging; Male; Memory Disorders; Multimodal Imaging; Mutation; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography; Protein Aggregation, Pathological; Radiopharmaceuticals; Rats; Rats, Transgenic; Rats, Wistar	2017
Association of the New Variant Tyr424Asp at TBK1 Gene with Amyotrophic Lateral Sclerosis and Cognitive Decline. Journal of Alzheimer's disease : JAD, 2018, Volume: 61, Issue:1 Topics: Aged; Amyotrophic Lateral Sclerosis; Aspartic Acid; C9orf72 Protein; Cognitive Dysfunction; DNA Mutational Analysis; Female; Fluorodeoxyglucose F18; Genetic Association Studies; Genetic Predisposition to Disease; Humans; Italy; Male; Mental Status and Dementia Tests; Middle Aged; Mutation; Neuropsychological Tests; Positron-Emission Tomography; Protein Serine-Threonine Kinases; Tyrosine	2018
Prediction of Alzheimer's Dementia in Patients with Amnestic Mild Cognitive Impairment in Clinical Routine: Incremental Value of Biomarkers of Neurodegeneration and Brain Amyloidosis Added Stepwise to Cognitive Status. Journal of Alzheimer's disease : JAD, 2018, Volume: 61, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Survival Analysis; tau Proteins	2018
Longitudinal uncoupling of cerebral perfusion, glucose metabolism, and tau deposition in Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2018, Volume: 14, Issue:5 Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Perfusion; Positron-Emission Tomography; Quinolines; tau Proteins	2018
A new data analysis approach for measuring longitudinal changes of metabolism in cognitively normal elderly adults. Clinical interventions in aging, 2017, Volume: 12 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoprotein E4; Biomarkers; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Time Factors	2017
FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort. NeuroImage. Clinical, 2018, Volume: 18 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Dementia; Humans; Male; Middle Aged; Neuropsychological Tests; Phosphorylation; Positron-Emission Tomography; Prognosis; Sensitivity and Specificity; tau Proteins	2018
Hypermetabolism in the hippocampal formation of cognitively impaired patients indicates detrimental maladaptation. Neurobiology of aging, 2018, Volume: 65 Topics: Adaptation, Physiological; Aged; Aged, 80 and over; Cognition; Cognitive Dysfunction; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Hippocampus; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Semantics; Verbal Behavior	2018
Conversion and time-to-conversion predictions of mild cognitive impairment using low-rank affinity pursuit denoising and matrix completion. Medical image analysis, 2018, Volume: 45 Topics: Aged; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals	2018
Joint Assessment of Quantitative 18F-Florbetapir and 18F-FDG Regional Uptake Using Baseline Data from the ADNI. Journal of Alzheimer's disease : JAD, 2018, Volume: 62, Issue:1 Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Brain Mapping; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity	2018
Anosognosia predicts default mode network hypometabolism and clinical progression to dementia. Neurology, 2018, 03-13, Volume: 90, Issue:11 Topics: Aged; Agnosia; Amyloid; Aniline Compounds; Apolipoprotein E4; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Prognosis; Radiopharmaceuticals	2018
Predicting cognitive decline with deep learning of brain metabolism and amyloid imaging. Behavioural brain research, 2018, 05-15, Volume: 344 Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine	2018
Impact of plasma glucose level on the pattern of brain FDG uptake and the predictive power of FDG PET in mild cognitive impairment. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:8 Topics: Aged; Alzheimer Disease; Blood Glucose; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography	2018
[18F]-Flutemetamol Uptake in Cortex and White Matter: Comparison with Cerebrospinal Fluid Biomarkers and [18F]-Fludeoxyglucose. Journal of Alzheimer's disease : JAD, 2018, Volume: 62, Issue:4 Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Biomarkers; Brain Mapping; Cerebral Cortex; Cognitive Dysfunction; Diagnostic Self Evaluation; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Perception; Radiopharmaceuticals; White Matter	2018
Amyloid load but not regional glucose metabolism predicts conversion to Alzheimer's dementia in a memory clinic population. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:8 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies	2018
Multi-Modality Sparse Representation for Alzheimer's Disease Classification. Journal of Alzheimer's disease : JAD, 2018, Volume: 65, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine	2018
Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD). Alzheimer's research & therapy, 2018, 04-03, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Brain; Cognitive Dysfunction; Cohort Studies; Disease Progression; Educational Status; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography	2018
Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET. Journal of Alzheimer's disease : JAD, 2018, Volume: 63, Issue:2 Topics: Aged; Alzheimer Disease; Apolipoproteins E; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity	2018
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images. Scientific reports, 2018, 04-09, Volume: 8, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Deep Learning; Early Diagnosis; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Neural Networks, Computer; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2018
A biomarker study in long-lasting amnestic mild cognitive impairment. Alzheimer's research & therapy, 2018, 04-25, Volume: 10, Issue:1 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins	2018
Semantic Intrusions and Failure to Recover From Semantic Interference in Mild Cognitive Impairment: Relationship to Amyloid and Cortical Thickness. Current Alzheimer research, 2018, Volume: 15, Issue:9 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Language Disorders; Language Therapy; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Semantics	2018
Simultaneous resting-state FDG-PET/fMRI in Alzheimer Disease: Relationship between glucose metabolism and intrinsic activity. NeuroImage, 2018, 08-01, Volume: 176 Topics: Adult; Aged; Aging; Alzheimer Disease; Amnesia; Cognitive Dysfunction; Connectome; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography	2018
Utility of Amyloid and FDG-PET in Clinical Practice: Differences Between Secondary and Tertiary Care Memory Units. Journal of Alzheimer's disease : JAD, 2018, Volume: 63, Issue:3 Topics: Aged; Amyloid; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurologists; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Tertiary Healthcare	2018
Visual Rating and Computer-Assisted Analysis of FDG PET in the Prediction of Conversion to Alzheimer's Disease in Mild Cognitive Impairment. Molecular diagnosis & therapy, 2018, Volume: 22, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Area Under Curve; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; ROC Curve	2018
Cerebrospinal Fluid BACE1 Activity and sAβPPβ as Biomarker Candidates of Alzheimer's Disease. Dementia and geriatric cognitive disorders, 2018, Volume: 45, Issue:3-4 Topics: Aged; Alzheimer Disease; Amyloid beta-Protein Precursor; Amyloid Precursor Protein Secretases; Aspartic Acid Endopeptidases; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2018
European Association of Nuclear Medicine and European Academy of Neurology recommendations for the use of brain European journal of neurology, 2018, Volume: 25, Issue:10 Topics: Brain; Cognitive Dysfunction; Consensus; Dementia; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Neurodegenerative Diseases; Nuclear Medicine; Positron-Emission Tomography; Sensitivity and Specificity	2018
Amyloid involvement in subcortical regions predicts cognitive decline. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:13 Topics: Aged; Amyloid; Brain; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Prognosis	2018
Regional glucose metabolism due to the presence of cerebral amyloidopathy in older adults with depression and mild cognitive impairment. Journal of affective disorders, 2018, 10-15, Volume: 239 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Depressive Disorder; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Stilbenes	2018
Clinical characteristics of cognitive impairment in patients with Parkinson's disease and its related pattern in Human brain mapping, 2018, Volume: 39, Issue:12 Topics: Adult; Aged; Aged, 80 and over; Attention; Cognitive Dysfunction; Dementia; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography	2018
Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease. European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:13 Topics: Aged; Brain Stem; Case-Control Studies; Cerebellum; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals	2018
Multilevel Feature Representation of FDG-PET Brain Images for Diagnosing Alzheimer's Disease. IEEE journal of biomedical and health informatics, 2019, Volume: 23, Issue:4 Topics: Algorithms; Alzheimer Disease; Brain; Cognitive Dysfunction; Databases, Factual; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Neuroimaging; Positron-Emission Tomography; Support Vector Machine	2019
Usefulness of Dual-Point Amyloid PET Scans in Appropriate Use Criteria: A Multicenter Study. Journal of Alzheimer's disease : JAD, 2018, Volume: 65, Issue:3 Topics: Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Dementia; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Mental Disorders; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Stilbenes	2018
Indirect relation based individual metabolic network for identification of mild cognitive impairment. Journal of neuroscience methods, 2018, 11-01, Volume: 309 Topics: Aged; Biomarkers; Brain Mapping; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Positron-Emission Tomography; ROC Curve	2018
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease. Scientific reports, 2018, 09-14, Volume: 8, Issue:1 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Nerve Net; Positron-Emission Tomography	2018
[Statistical parametric mapping analysis of Zhonghua yi xue za zhi, 2018, Sep-04, Volume: 98, Issue:33 Topics: Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Parkinson Disease; Positron-Emission Tomography	2018
Association of vascular endothelial growth factor levels in CSF and cerebral glucose metabolism across the Alzheimer's disease spectrum. Neuroscience letters, 2018, 11-20, Volume: 687 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Vascular Endothelial Growth Factor A	2018
Amyloid and FDG PET of Successful Cognitive Aging: Global and Cingulate-Specific Differences. Journal of Alzheimer's disease : JAD, 2018, Volume: 66, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Aging; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Gyrus Cinguli; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography	2018
Discriminative Accuracy of [18F]flortaucipir Positron Emission Tomography for Alzheimer Disease vs Other Neurodegenerative Disorders. JAMA, 2018, 09-18, Volume: 320, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Area Under Curve; Carbolines; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurodegenerative Diseases; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2018
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2019, Volume: 15, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Bile Acids and Salts; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Prospective Studies; tau Proteins	2019
Principal Components Analysis of Brain Metabolism Predicts Development of Alzheimer Dementia. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2019, Volume: 60, Issue:6 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Principal Component Analysis; Proportional Hazards Models; Risk Assessment	2019
A Deep Learning Model to Predict a Diagnosis of Alzheimer Disease by Using Radiology, 2019, Volume: 290, Issue:2 Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Cognitive Dysfunction; Deep Learning; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Sensitivity and Specificity	2019
Plasma Aβ42/40 Ratio Detects Early Stages of Alzheimer's Disease and Correlates with CSF and Neuroimaging Biomarkers in the AB255 Study. The journal of prevention of Alzheimer's disease, 2019, Volume: 6, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Apolipoproteins E; Biomarkers; Case-Control Studies; Cognitive Dysfunction; Cross-Sectional Studies; Early Diagnosis; Female; Fluorodeoxyglucose F18; Genotype; Humans; Male; Neuroimaging; Peptide Fragments; Phosphorylation; Plaque, Amyloid; Positron-Emission Tomography; Prodromal Symptoms; tau Proteins; Thiazoles	2019
Cognitive, behavioral and metabolic effects of oral galactose treatment in the transgenic Tg2576 mice. Neuropharmacology, 2019, Volume: 148 Topics: Administration, Oral; Alzheimer Disease; Amyloid beta-Peptides; Animals; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Functional Neuroimaging; Galactose; Glucagon-Like Peptide 1; Glucose Tolerance Test; Glycogen Synthase Kinase 3 beta; Hippocampus; Insulin; Male; Maze Learning; Mice; Mice, Transgenic; Peptide Fragments; Positron-Emission Tomography; Rats; Receptor, Insulin; Streptozocin	2019
Relative cerebral flow from dynamic PIB scans as an alternative for FDG scans in Alzheimer's disease PET studies. PloS one, 2019, Volume: 14, Issue:1 Topics: Aged; Alzheimer Disease; Aniline Compounds; Brain; Carbon Radioisotopes; Case-Control Studies; Cerebrovascular Circulation; Cognitive Dysfunction; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles	2019
Correlation of Lobar Cerebral Microbleeds with Amyloid, Perfusion, and Metabolism in Alzheimer's Disease. Journal of Alzheimer's disease : JAD, 2019, Volume: 68, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cerebral Hemorrhage; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography	2019
The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study. NeuroImage. Clinical, 2019, Volume: 22 Topics: Aged; Aged, 80 and over; Apolipoprotein E4; Apolipoproteins E; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography	2019
Deep learning only by normal brain PET identify unheralded brain anomalies. EBioMedicine, 2019, Volume: 43 Topics: Alzheimer Disease; Area Under Curve; Brain; Brain Diseases; Cognitive Dysfunction; Deep Learning; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Neuroimaging; Positron-Emission Tomography; ROC Curve	2019
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease. JAMA neurology, 2019, 07-01, Volume: 76, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Case-Control Studies; Cerebral Cortex; Cerebral Ventricles; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status and Dementia Tests; Neurofilament Proteins; Organ Size; Peptide Fragments; Phosphoproteins; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins	2019
A ketogenic drink improves brain energy and some measures of cognition in mild cognitive impairment. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2019, Volume: 15, Issue:5 Topics: Aged; Brain; Cognitive Dysfunction; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Humans; Ketones; Male; Neuropsychological Tests; Positron-Emission Tomography	2019
Biopathological Significance of Early-Phase Amyloid Imaging in the Spectrum of Alzheimer's Disease. Journal of Alzheimer's disease : JAD, 2019, Volume: 69, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Carbon Radioisotopes; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Thiazoles	2019
Aβ-induced vulnerability propagates via the brain's default mode network. Nature communications, 2019, 06-04, Volume: 10, Issue:1 Topics: Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Animals; Animals, Genetically Modified; Brain; Cognitive Dysfunction; Ethylene Glycols; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Neural Pathways; Neurofibrillary Tangles; Positron-Emission Tomography; Radiopharmaceuticals; Rats	2019
Plasma and CSF neurofilament light: Relation to longitudinal neuroimaging and cognitive measures. Neurology, 2019, 07-16, Volume: 93, Issue:3 Topics: Aged; Aniline Compounds; Attention; Brain; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Linear Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neurofilament Proteins; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles	2019
The Cingulate Island Sign on FDG-PET vs. IMP-SPECT to Assess Mild Cognitive Impairment in Alzheimer's Disease vs. Dementia with Lewy Bodies. Journal of neuroimaging : official journal of the American Society of Neuroimaging, 2019, Volume: 29, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Middle Aged; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon	2019
Predicting long-term clinical stability in amyloid-positive subjects by FDG-PET. Annals of clinical and translational neurology, 2019, Volume: 6, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Clinical Trials as Topic; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Healthy Volunteers; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography	2019
Metabolic Brain Network Analysis of FDG-PET in Alzheimer's Disease Using Kernel-Based Persistent Features. Molecules (Basel, Switzerland), 2019, Jun-21, Volume: 24, Issue:12 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Metabolic Networks and Pathways; Positron-Emission Tomography	2019
FDG-PET as an independent biomarker for Alzheimer's biological diagnosis: a longitudinal study. Alzheimer's research & therapy, 2019, 06-29, Volume: 11, Issue:1 Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Positron-Emission Tomography	2019
Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset. Journal of neurology, 2019, Volume: 266, Issue:10 Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Datasets as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; tau Proteins	2019
18F-FDG Is a Superior Indicator of Cognitive Performance Compared to 18F-Florbetapir in Alzheimer's Disease and Mild Cognitive Impairment Evaluation: A Global Quantitative Analysis. Journal of Alzheimer's disease : JAD, 2019, Volume: 70, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Mental Status and Dementia Tests; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2019
Clinical utility of 18F-FDG-PET/MRI brain in dementia: Preliminary experience from a geriatric clinic in South India. Asian journal of psychiatry, 2019, Volume: 44 Topics: Adult; Aged; Biomarkers; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; India; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals	2019
Controls-based denoising, a new approach for medical image analysis, improves prediction of conversion to Alzheimer's disease with FDG-PET. European journal of nuclear medicine and molecular imaging, 2019, Volume: 46, Issue:11 Topics: Aged; Algorithms; Alzheimer Disease; Brain; Cognitive Dysfunction; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Machine Learning; Male; Middle Aged; Models, Theoretical; Pattern Recognition, Automated; Positron-Emission Tomography; Principal Component Analysis; Signal-To-Noise Ratio	2019
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers. JAMA network open, 2019, 07-03, Volume: 2, Issue:7 Topics: Aged; Alanine Transaminase; Alkaline Phosphatase; Alzheimer Disease; Aspartate Aminotransferases; Bilirubin; Biomarkers; Cognition; Cognitive Dysfunction; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Liver Function Tests; Magnetic Resonance Imaging; Male; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; Reproducibility of Results; Serum Albumin	2019
Relationship Between the Japanese Version of the Montreal Cognitive Assessment and PET Imaging in Subjects with Mild Cognitive Impairment. Current Alzheimer research, 2019, Volume: 16, Issue:9 Topics: Aged; Amyloid; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Mental Status and Dementia Tests; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals	2019
Comparing brain amyloid deposition, glucose metabolism, and atrophy in mild cognitive impairment with and without a family history of dementia. Journal of Alzheimer's disease : JAD, 2013, Volume: 35, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis, Familial; Atrophy; Blood Glucose; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Reference Values	2013
Regional amyloid deposition in amnestic mild cognitive impairment and Alzheimer's disease evaluated by [18F]AV-45 positron emission tomography in Chinese population. PloS one, 2013, Volume: 8, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Amyloid; Asian People; Brain; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography	2013
Evoked potentials and neuropsychological tests validate Positron Emission Topography (PET) brain metabolism in cognitively impaired patients. PloS one, 2013, Volume: 8, Issue:3 Topics: Adult; Aged; Brain; Cognition Disorders; Cognitive Dysfunction; Event-Related Potentials, P300; Fluorodeoxyglucose F18; Humans; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals	2013
Comparison of different methods of spatial normalization of FDG-PET brain images in the voxel-wise analysis of MCI patients and controls. Annals of nuclear medicine, 2013, Volume: 27, Issue:7 Topics: Aged; Brain; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Sensitivity and Specificity	2013
Amyloid cascade and tau pathology cerebrospinal fluid markers in mild cognitive impairment with regards to Alzheimer's disease cerebral metabolic signature. Journal of Alzheimer's disease : JAD, 2013, Volume: 36, Issue:2 Topics: Adaptor Proteins, Vesicular Transport; Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Apolipoprotein E4; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Psychiatric Status Rating Scales; Statistics, Nonparametric; tau Proteins	2013
FDG-PET in early AD diagnosis. The Medical clinics of North America, 2013, Volume: 97, Issue:3 Topics: Aged; Alzheimer Disease; Asymptomatic Diseases; Blood Glucose; Brain; Cognitive Dysfunction; Diagnosis, Differential; Disease Progression; Early Diagnosis; Energy Metabolism; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Neuropsychological Tests; Positron-Emission Tomography; Prognosis	2013
Automated analysis of FDG PET as a tool for single-subject probabilistic prediction and detection of Alzheimer's disease dementia. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:9 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Models, Statistical; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals	2013
Diagnosed mild cognitive impairment due to Alzheimer's disease with PET biomarkers of beta amyloid and neuronal dysfunction. PloS one, 2013, Volume: 8, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Biomarkers; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Thiazoles	2013
[11C]PIB, [18F]FDG and MR imaging in patients with mild cognitive impairment. European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:10 Topics: Aged; Aniline Compounds; Benzothiazoles; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thiazoles	2013
Loss of olfactory tract integrity affects cortical metabolism in the brain and olfactory regions in aging and mild cognitive impairment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2013, Volume: 54, Issue:8 Topics: Aged; Aging; Anisotropy; Axons; Case-Control Studies; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Nerve Net; Olfactory Pathways; Positron-Emission Tomography	2013
Cholinergic activity correlates with reserve proxies in Alzheimer's disease. Neurobiology of aging, 2013, Volume: 34, Issue:11 Topics: Acetates; Acetylcholine; Aged; Aged, 80 and over; Alzheimer Disease; Carbon Isotopes; Cognitive Dysfunction; Cognitive Reserve; Educational Status; Employment; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Status Schedule; Middle Aged; Piperidines; Positron-Emission Tomography; Radiography; Statistics, Nonparametric; Tomography Scanners, X-Ray Computed	2013
Glucose metabolism during resting state reveals abnormal brain networks organization in the Alzheimer's disease and mild cognitive impairment. PloS one, 2013, Volume: 8, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain Mapping; Case-Control Studies; Cell Physiological Phenomena; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography	2013
Identification and mapping of linear antibody epitopes in human serum albumin using high-density Peptide arrays. PloS one, 2013, Volume: 8, Issue:7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Animals; Brain Mapping; Case-Control Studies; Cattle; Cell Physiological Phenomena; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Longitudinal Studies; Male; Middle Aged; Neural Networks, Computer; Neuroimaging; Positron-Emission Tomography; Rabbits	2013
Visual-statistical interpretation of (18)F-FDG-PET images for characteristic Alzheimer patterns in a multicenter study: inter-rater concordance and relationship to automated quantitative evaluation. AJNR. American journal of neuroradiology, 2014, Volume: 35, Issue:2 Topics: Algorithms; Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Data Interpretation, Statistical; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Japan; Male; Middle Aged; Observer Variation; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2014
Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia. Neurobiology of aging, 2014, Volume: 35, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Brain; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Forecasting; Genotype; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Temporal Lobe; Thiazoles	2014
Classification of Alzheimer's disease from FDG-PET images using favourite class ensembles. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2013, Volume: 2013 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Neuroimaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals; Support Vector Machine	2013
Apathy is associated with increased amyloid burden in mild cognitive impairment. The Journal of neuropsychiatry and clinical neurosciences, 2013,Fall, Volume: 25, Issue:4 Topics: Aged; Aged, 80 and over; Amyloid; Aniline Compounds; Apathy; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles	2013
Reduced FDG-PET brain metabolism and executive function predict clinical progression in elderly healthy subjects. NeuroImage. Clinical, 2014, Volume: 4 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Cerebral Cortex; Cognitive Dysfunction; Disease Progression; Executive Function; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Logistic Models; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests; ROC Curve	2014
Plasma antioxidants and brain glucose metabolism in elderly subjects with cognitive complaints. European journal of nuclear medicine and molecular imaging, 2014, Volume: 41, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Catalase; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Glutathione Peroxidase; Humans; Male; Middle Aged; Oxidative Stress; Positron-Emission Tomography; Radiopharmaceuticals; Superoxide Dismutase	2014
White matter lesion load is associated with resting state functional MRI activity and amyloid PET but not FDG in mild cognitive impairment and early Alzheimer's disease patients. Journal of magnetic resonance imaging : JMRI, 2015, Volume: 41, Issue:1 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Rest; White Matter	2015
Analysis of early phase [11C]BF-227 PET, and its application for anatomical standardization of late-phase images for 3D-SSP analysis. Japanese journal of radiology, 2014, Volume: 32, Issue:3 Topics: Aged; Alzheimer Disease; Benzoxazoles; Brain; Carbon Radioisotopes; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Male; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Thiazoles	2014
Regional neuronal network failure and cognition in late-onset sporadic Alzheimer disease. AJNR. American journal of neuroradiology, 2014, Volume: 35, Issue:6 Suppl Topics: Age of Onset; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Nerve Net; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals	2014
Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition. Acta neuropathologica communications, 2014, Mar-06, Volume: 2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Cohort Studies; Cross-Sectional Studies; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Peptide Fragments; Psychiatric Status Rating Scales; Radionuclide Imaging; tau Proteins; Time Factors	2014
Extension and refinement of the predictive value of different classes of markers in ADNI: four-year follow-up data. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2014, Volume: 10, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Apolipoproteins E; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Memory, Episodic; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; tau Proteins	2014
Evaluation of the posterior cingulate region with FDG-PET and advanced MR techniques in patients with amnestic mild cognitive impairment: comparison of the methods. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:1 Topics: Aged; Amnesia; Anisotropy; Case-Control Studies; Cognitive Dysfunction; Diagnostic Imaging; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Gyrus Cinguli; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Perfusion Imaging; Positron-Emission Tomography; Regression Analysis; Retrospective Studies	2015
18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons. Neurobiology of aging, 2014, Volume: 35, Issue:9 Topics: Adult; Aged; Aged, 80 and over; Aging; Alleles; Alzheimer Disease; Apolipoprotein E4; Brain; Cognitive Dysfunction; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Genotype; Glucose; Heterozygote; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2014
β-Amyloid is associated with aberrant metabolic connectivity in subjects with mild cognitive impairment. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014, Volume: 34, Issue:7 Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Apolipoprotein E4; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Genotype; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Radiopharmaceuticals	2014
Distinct pattern of hypometabolism and atrophy in preclinical and predementia Alzheimer's disease. Neurobiology of aging, 2014, Volume: 35, Issue:9 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidogenic Proteins; Atrophy; Cognitive Dysfunction; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gray Matter; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Synapses	2014
Limited agreement between biomarkers of neuronal injury at different stages of Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2014, Volume: 10, Issue:6 Topics: Aged; Alzheimer Disease; Apolipoproteins E; Atrophy; Biomarkers; Chi-Square Distribution; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; tau Proteins	2014
Regional fluorodeoxyglucose metabolism and instrumental activities of daily living across the Alzheimer's disease spectrum. Journal of Alzheimer's disease : JAD, 2014, Volume: 42, Issue:1 Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Cross-Sectional Studies; Databases, Factual; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Surveys and Questionnaires	2014
Alzheimer's disease-like pattern of (18)F-FDG uptake during a hyperglycemic state and negative (11)C-PiB binding in a patient with mild cognitive impairment. Journal of Alzheimer's disease : JAD, 2014, Volume: 42, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Benzothiazoles; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Hyperglycemia; Male; Middle Aged; Positron-Emission Tomography; Thiazoles	2014
Card-placing test in amnestic mild cognitive impairment and its neural correlates. BMC neurology, 2014, Jun-06, Volume: 14 Topics: Age Factors; Aged; Brain; Brain Chemistry; Brain Mapping; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Socioeconomic Factors	2014
Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process. Brain : a journal of neurology, 2014, Volume: 137, Issue:Pt 8 Topics: Aged; Aged, 80 and over; Atrophy; Cerebral Cortex; Cognitive Dysfunction; Cross-Sectional Studies; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index	2014
A standardized [18F]-FDG-PET template for spatial normalization in statistical parametric mapping of dementia. Neuroinformatics, 2014, Volume: 12, Issue:4 Topics: Aged; Aged, 80 and over; Brain; Brain Mapping; Case-Control Studies; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Sensitivity and Specificity	2014
Apathy as a feature of prodromal Alzheimer's disease: an FDG-PET ADNI study. International journal of geriatric psychiatry, 2015, Volume: 30, Issue:5 Topics: Aged; Alzheimer Disease; Apathy; Atrophy; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography	2015
Temporal evolution of biomarkers and cognitive markers in the asymptomatic, MCI, and dementia stage of Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2015, Volume: 11, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins	2015
The use of biomarkers for the etiologic diagnosis of MCI in Europe: an EADC survey. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2015, Volume: 11, Issue:2 Topics: Alzheimer Disease; Amyloid beta-Peptides; Atrophy; Biomarkers; Brain; Cognitive Dysfunction; Europe; Fluorodeoxyglucose F18; Internet; Magnetic Resonance Imaging; Peptide Fragments; Positron-Emission Tomography; Practice Patterns, Physicians'; Radiopharmaceuticals; Surveys and Questionnaires; tau Proteins	2015
Influence of microglial activation on neuronal function in Alzheimer's and Parkinson's disease dementia. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2015, Volume: 11, Issue:6 Topics: Alzheimer Disease; Amyloid; Brain; Brain Mapping; Carbon Radioisotopes; Cognitive Dysfunction; Fluorodeoxyglucose F18; Glucose; Humans; Isoquinolines; Magnetic Resonance Imaging; Microglia; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Signal Processing, Computer-Assisted	2015
Manifold regularized multitask feature learning for multimodality disease classification. Human brain mapping, 2015, Volume: 36, Issue:2 Topics: Aged; Algorithms; Alzheimer Disease; Artificial Intelligence; Brain; Brain Mapping; Cognitive Dysfunction; Databases, Factual; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Multimodal Imaging; Pattern Recognition, Automated; Positron-Emission Tomography; Radiopharmaceuticals	2015
Studying ventricular abnormalities in mild cognitive impairment with hyperbolic Ricci flow and tensor-based morphometry. NeuroImage, 2015, Jan-01, Volume: 104 Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Cerebral Ventricles; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Models, Neurological; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals	2015
Hierarchical multivariate covariance analysis of metabolic connectivity. Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2014, Volume: 34, Issue:12 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Brain; Cognitive Dysfunction; Connectome; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolome; Middle Aged; Models, Neurological; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals	2014
Hole detection in metabolic connectivity of Alzheimer's disease using kappa-Laplacian. Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention, 2014, Volume: 17, Issue:Pt 3 Topics: Algorithms; Alzheimer Disease; Artificial Intelligence; Brain; Cognitive Dysfunction; Connectome; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Radionuclide Imaging; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2014
Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment. Acta psychiatrica Scandinavica, 2015, Volume: 131, Issue:2 Topics: Adult; Aged; Alzheimer Disease; Biomarkers; Cerebral Cortex; Cognition Disorders; Cognitive Dysfunction; Depression; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2015
Visual versus semi-quantitative analysis of 18F-FDG-PET in amnestic MCI: an European Alzheimer's Disease Consortium (EADC) project. Journal of Alzheimer's disease : JAD, 2015, Volume: 44, Issue:3 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Europe; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Sensitivity and Specificity	2015
Cerebral and blood correlates of reduced functional connectivity in mild cognitive impairment. Brain structure & function, 2016, Volume: 221, Issue:1 Topics: Age Factors; Aged; Alpha Rhythm; Amyloid beta-Peptides; Apolipoprotein B-100; Apolipoprotein E4; Biomarkers; Brain Mapping; Case-Control Studies; Cerebral Cortex; Cholesterol, HDL; Cognition; Cognitive Dysfunction; Electroencephalography; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Lipids; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Triglycerides	2016
Measurement of inter- and intra-observer variability in the routine clinical interpretation of brain 18-FDG PET-CT. Annals of nuclear medicine, 2015, Volume: 29, Issue:3 Topics: Aged; Brain; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Frail Elderly; Humans; Male; Multimodal Imaging; Observer Variation; Positron-Emission Tomography; Prospective Studies; Reproducibility of Results; Tomography, X-Ray Computed	2015
The mediational effects of FDG hypometabolism on the association between cerebrospinal fluid biomarkers and neurocognitive function. NeuroImage, 2015, Jan-15, Volume: 105 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2015
Alteration patterns of brain glucose metabolism: comparisons of healthy controls, subjective memory impairment and mild cognitive impairment. Acta radiologica (Stockholm, Sweden : 1987), 2016, Volume: 57, Issue:1 Topics: Aged; Brain; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals	2016
18F-FDG and 18F-florbetapir PET in clinical practice: regional analysis in mild cognitive impairment and Alzheimer disease. Clinical nuclear medicine, 2015, Volume: 40, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2015
Longitudinal FDG-PET features for the classification of Alzheimer's disease. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference, 2014, Volume: 2014 Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Cross-Sectional Studies; Data Collection; Databases, Factual; Diagnosis, Computer-Assisted; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Reproducibility of Results	2014
Prediction of Outcomes in Mild Cognitive Impairment by Using 18F-FDG-PET: A Multicenter Study. Journal of Alzheimer's disease : JAD, 2015, Volume: 45, Issue:2 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Sensitivity and Specificity	2015
Volume of interest-based [18F]fluorodeoxyglucose PET discriminates MCI converting to Alzheimer's disease from healthy controls. A European Alzheimer's Disease Consortium (EADC) study. NeuroImage. Clinical, 2015, Volume: 7 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2015
Brain metabolic maps in Mild Cognitive Impairment predict heterogeneity of progression to dementia. NeuroImage. Clinical, 2015, Volume: 7 Topics: Aged; Brain; Brain Mapping; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiographic Image Interpretation, Computer-Assisted; Radiopharmaceuticals	2015
Depressive symptoms accelerate cognitive decline in amyloid-positive MCI patients. European journal of nuclear medicine and molecular imaging, 2015, Volume: 42, Issue:5 Topics: Aged; Aged, 80 and over; Case-Control Studies; Cognitive Dysfunction; Depression; Female; Fluorodeoxyglucose F18; Humans; Male; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals	2015
Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, 2015, Volume: 45, Issue:3 Topics: Aged; Amyloid beta-Peptides; Analysis of Variance; Apolipoprotein E4; Brain Mapping; Cerebral Cortex; Cognitive Dysfunction; Databases, Factual; Depression; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography	2015
Cognitive dysfunction in patients with very mild Alzheimer's disease and amnestic mild cognitive impairment showing hemispheric asymmetries of hypometabolism on ¹⁸F-FDG PET. International journal of geriatric psychiatry, 2016, Volume: 31, Issue:1 Topics: Aged; Alzheimer Disease; Amnesia; Brain; Cerebral Cortex; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals	2016
Effects of Aerobic Training on Cognition and Brain Glucose Metabolism in Subjects with Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, 2015, Volume: 46, Issue:3 Topics: Aged; Brain; Cognitive Dysfunction; Exercise; Exercise Therapy; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Oxygen Consumption; Positron-Emission Tomography	2015
Cognitive Correlates of Basal Forebrain Atrophy and Associated Cortical Hypometabolism in Mild Cognitive Impairment. Cerebral cortex (New York, N.Y. : 1991), 2016, Volume: 26, Issue:6 Topics: Aged; Amyloid; Atrophy; Brain; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Signal Processing, Computer-Assisted	2016
Neuropsychological Testing Predicts Cerebrospinal Fluid Amyloid-β in Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, 2015, Volume: 46, Issue:4 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Apolipoproteins E; Area Under Curve; Cognitive Dysfunction; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Verbal Learning	2015
Connectivity analysis of normal and mild cognitive impairment patients based on FDG and PiB-PET images. Neuroscience research, 2015, Volume: 98 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Case-Control Studies; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles	2015
FDG-PET in the Evaluation of Brain Metabolic Changes Induced by Cognitive Stimulation in aMCI Subjects. Current radiopharmaceuticals, 2015, Volume: 8, Issue:1 Topics: Aged; Aged, 80 and over; Brain; Case-Control Studies; Cognitive Dysfunction; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Male; Memory, Short-Term; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; Random Allocation	2015
Multiple testing for neuroimaging via hidden Markov random field. Biometrics, 2015, Volume: 71, Issue:3 Topics: Algorithms; Alzheimer Disease; Cognitive Dysfunction; Computer Simulation; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Markov Chains; Models, Statistical; Neuroimaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2015
Multimodal Discrimination of Alzheimer's Disease Based on Regional Cortical Atrophy and Hypometabolism. PloS one, 2015, Volume: 10, Issue:6 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity	2015
Brain structural, functional, and cognitive correlates of recent versus remote autobiographical memories in amnestic Mild Cognitive Impairment. NeuroImage. Clinical, 2015, Volume: 8 Topics: Aged; Aged, 80 and over; Amnesia; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Memory, Episodic; Mental Recall; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors	2015
The relative importance of imaging markers for the prediction of Alzheimer's disease dementia in mild cognitive impairment - Beyond classical regression. NeuroImage. Clinical, 2015, Volume: 8 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis	2015
Comparison of Visual and Quantitative Florbetapir F 18 Positron Emission Tomography Analysis in Predicting Mild Cognitive Impairment Outcomes. JAMA neurology, 2015, Volume: 72, Issue:10 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Male; Middle Aged; Positron-Emission Tomography; Predictive Value of Tests; Treatment Outcome	2015
Discriminative multi-task feature selection for multi-modality classification of Alzheimer's disease. Brain imaging and behavior, 2016, Volume: 10, Issue:3 Topics: Algorithms; Alzheimer Disease; Cognitive Dysfunction; Datasets as Topic; Fluorodeoxyglucose F18; Humans; Linear Models; Magnetic Resonance Imaging; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve	2016
Effects of imaging modalities, brain atlases and feature selection on prediction of Alzheimer's disease. Journal of neuroscience methods, 2015, Dec-30, Volume: 256 Topics: Aged; Alzheimer Disease; Atlases as Topic; Brain; Cognitive Dysfunction; Cohort Studies; Datasets as Topic; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Sensitivity and Specificity; Support Vector Machine	2015
Cross-validation of biomarkers for the early differential diagnosis and prognosis of dementia in a clinical setting. European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Diagnosis, Differential; Disease Progression; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Humans; Lewy Body Disease; Magnetic Resonance Imaging; Male; Middle Aged; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; Reproducibility of Results; tau Proteins	2016
Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects. Alzheimer's research & therapy, 2015, Sep-15, Volume: 7, Issue:1 Topics: Aged; Amnesia; Amyloid beta-Peptides; Biomarkers; Brain; Brain Mapping; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Phosphorylation; Radionuclide Imaging; Radiopharmaceuticals; tau Proteins	2015
Metabolic Topology of Neurodegenerative Disorders: Influence of Cognitive and Motor Deficits. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2015, Volume: 56, Issue:12 Topics: Aged; Alzheimer Disease; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Lewy Body Disease; Male; Movement Disorders; Neurodegenerative Diseases; Parkinson Disease; Parkinson Disease, Postencephalitic; Radionuclide Imaging; Radiopharmaceuticals	2015
Alzheimer's Disease FDG PET Imaging Pattern in an Amyloid-Negative Mild Cognitive Impairment Subject. Journal of Alzheimer's disease : JAD, 2015, Volume: 47, Issue:3 Topics: Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Diagnosis, Differential; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals	2015
Long-Term Interrelationship between Brain Metabolism and Amyloid Deposition in Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, 2015, Volume: 48, Issue:1 Topics: Aged; Amyloid; Aniline Compounds; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography; Thiazoles	2015
Regional brain hypometabolism is unrelated to regional amyloid plaque burden. Brain : a journal of neurology, 2015, Volume: 138, Issue:Pt 12 Topics: Aged; Aniline Compounds; Atrophy; Brain; Case-Control Studies; Cognitive Dysfunction; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Plaque, Amyloid; Positron-Emission Tomography	2015
Role of β-Amyloidosis and Neurodegeneration in Subsequent Imaging Changes in Mild Cognitive Impairment. JAMA neurology, 2015, Volume: 72, Issue:12 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloidosis; Aniline Compounds; Cognitive Dysfunction; Cohort Studies; Disease Progression; Female; Fluorodeoxyglucose F18; Gray Matter; Humans; Male; Neurodegenerative Diseases; Positron-Emission Tomography; Thiazoles	2015
Functional neural correlates of figure copy and recall task performances in cognitively impaired individuals: an 18F-FDG-PET study. Neuroreport, 2015, Dec-02, Volume: 26, Issue:17 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Mental Recall; Neuropsychological Tests; Positron-Emission Tomography; Visual Perception	2015
Early astrocytosis in autosomal dominant Alzheimer's disease measured in vivo by multi-tracer positron emission tomography. Scientific reports, 2015, Nov-10, Volume: 5 Topics: Age of Onset; Aged; Alzheimer Disease; Amyloid beta-Peptides; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Genes, Dominant; Genotype; Gliosis; Humans; Male; Memory, Episodic; Middle Aged; Mutation; Neuropsychological Tests; Plaque, Amyloid; Positron-Emission Tomography; Principal Component Analysis	2015
Does posterior cingulate hypometabolism result from disconnection or local pathology across preclinical and clinical stages of Alzheimer's disease? European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:3 Topics: Aged; Aging; Alzheimer Disease; Atrophy; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Gray Matter; Gyrus Cinguli; Hippocampus; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography	2016
Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum. Neuro-degenerative diseases, 2016, Volume: 16, Issue:1-2 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Brain; Cerebrovascular Circulation; Cognitive Dysfunction; Cross-Sectional Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Radiopharmaceuticals; Regional Blood Flow; ROC Curve; Severity of Illness Index	2016
Label-aligned multi-task feature learning for multimodal classification of Alzheimer's disease and mild cognitive impairment. Brain imaging and behavior, 2016, Volume: 10, Issue:4 Topics: Aged; Alzheimer Disease; Brain; Cognitive Dysfunction; Databases, Factual; Disease Progression; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Machine Learning; Multimodal Imaging; Neuroimaging; Pattern Recognition, Automated; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve	2016
Optimization of Statistical Single Subject Analysis of Brain FDG PET for the Prognosis of Mild Cognitive Impairment-to-Alzheimer's Disease Conversion. Journal of Alzheimer's disease : JAD, 2016, Volume: 49, Issue:4 Topics: Aged; Alzheimer Disease; Area Under Curve; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Image Interpretation, Computer-Assisted; Male; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve	2016
Visual Versus Fully Automated Analyses of 18F-FDG and Amyloid PET for Prediction of Dementia Due to Alzheimer Disease in Mild Cognitive Impairment. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Cognitive Dysfunction; Dementia; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Observer Variation; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Thiazoles	2016
Accurate Prediction of Conversion to Alzheimer's Disease using Imaging, Genetic, and Neuropsychological Biomarkers. Journal of Alzheimer's disease : JAD, 2016, Volume: 49, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Apolipoproteins E; Area Under Curve; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity	2016
Significance of visual hallucinations and cerebral hypometabolism in the risk of dementia in Parkinson's disease patients with mild cognitive impairment. Human brain mapping, 2016, Volume: 37, Issue:3 Topics: Aged; Brain; Brain Mapping; Cognitive Dysfunction; Comorbidity; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Hallucinations; Humans; Male; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography; Radiopharmaceuticals; Risk Factors	2016
Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment. Journal of Alzheimer's disease : JAD, 2016, Volume: 51, Issue:1 Topics: Aged; Brain; Cognitive Dysfunction; Cues; Female; Fluorodeoxyglucose F18; Humans; Male; Memory Disorders; Memory, Episodic; Mental Recall; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography	2016
Multimodal Magnetic Resonance Imaging in Alzheimer's Disease Patients at Prodromal Stage. Journal of Alzheimer's disease : JAD, 2016, Volume: 50, Issue:4 Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Diffusion Tensor Imaging; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Status Schedule; Multimodal Imaging; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals	2016
Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT. Psychiatry research. Neuroimaging, 2016, Mar-30, Volume: 249 Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Early Diagnosis; Female; Fluorodeoxyglucose F18; Humans; Imaging, Three-Dimensional; Iofetamine; Lewy Body Disease; Male; Middle Aged; Occipital Lobe; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Tomography, Emission-Computed, Single-Photon	2016
Use of dynamic (18)F-fluorodeoxyglucose positron emission tomography to investigate choroid plexus function in Alzheimer's disease. Experimental gerontology, 2016, Volume: 77 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Choroid Plexus; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; ROC Curve	2016
Comparison of Early-Phase 11C-Deuterium-l-Deprenyl and 11C-Pittsburgh Compound B PET for Assessing Brain Perfusion in Alzheimer Disease. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2016, Volume: 57, Issue:7 Topics: Aged; Alzheimer Disease; Aniline Compounds; Cerebellum; Cerebrovascular Circulation; Cognitive Dysfunction; Deuterium; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Gliosis; Gray Matter; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Perfusion; Pons; Positron-Emission Tomography; Radiopharmaceuticals; Selegiline; Thiazoles	2016
What are the Most Frequently Impaired Markers of Neurodegeneration in ADNI Subjects? Journal of Alzheimer's disease : JAD, 2016, Volume: 51, Issue:3 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Brain; Cognitive Dysfunction; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Male; Peptide Fragments; Phosphorylation; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins	2016
Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers. Journal of Alzheimer's disease : JAD, 2016, Volume: 51, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography; Predictive Value of Tests; Psychiatric Status Rating Scales; Sensitivity and Specificity	2016
Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease. Brain : a journal of neurology, 2016, Volume: 139, Issue:Pt 5 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid; Aniline Compounds; Apolipoproteins E; Benzothiazoles; Brain; Carbolines; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Positron-Emission Tomography; tau Proteins; Thiazoles	2016
Alzheimer's Disease Brain Areas: The Machine Learning Support for Blind Localization. Current Alzheimer research, 2016, Volume: 13, Issue:5 Topics: Aged; Aged, 80 and over; Algorithms; Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Databases, Factual; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Machine Learning; Male; Mental Status Schedule; Middle Aged; Positron-Emission Tomography	2016
Functional Biomedical Images of Alzheimer's Disease. A Green's Function-based Empirical Mode Decomposition Study. Current Alzheimer research, 2016, Volume: 13, Issue:6 Topics: Alzheimer Disease; Brain; Brain Mapping; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Nonlinear Dynamics; Positron-Emission Tomography; Radiopharmaceuticals; Support Vector Machine	2016
Impact of MRI-based Segmentation Artifacts on Amyloid- and FDG-PET Quantitation. Current Alzheimer research, 2016, Volume: 13, Issue:5 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid; Aniline Compounds; Artifacts; Brain; Brain Mapping; Cognitive Dysfunction; Cohort Studies; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Positron-Emission Tomography	2016
Cerebral Metabolic Differences Associated with Cognitive Impairment in Parkinson's Disease. PloS one, 2016, Volume: 11, Issue:4 Topics: Aged; Brain; Cerebral Cortex; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Levodopa; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Positron-Emission Tomography	2016
Prediction of Alzheimer's Disease in Amnestic Mild Cognitive Impairment Subtypes: Stratification Based on Imaging Biomarkers. Journal of Alzheimer's disease : JAD, 2016, 04-12, Volume: 52, Issue:4 Topics: Aged; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Hippocampus; Humans; Magnetic Resonance Imaging; Male; Neuroimaging; Positron-Emission Tomography; Temporal Lobe	2016
Comparability of [ Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism, 2017, Volume: 37, Issue:2 Topics: Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Positron-Emission Tomography; Quinolines; Radiopharmaceuticals; Thiazoles	2017
Accelerating rates of cognitive decline and imaging markers associated with β-amyloid pathology. Neurology, 2016, 05-17, Volume: 86, Issue:20 Topics: Aged; Amyloid beta-Peptides; Aniline Compounds; Atrophy; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Radiopharmaceuticals; Regression Analysis	2016
Patients with Amyloid-Negative Mild Cognitive Impairment have Cortical Hypometabolism but the Hippocampus is Preserved. Journal of Alzheimer's disease : JAD, 2016, 05-23, Volume: 53, Issue:2 Topics: Aged; Aged, 80 and over; Amyloid beta-Peptides; Apolipoproteins E; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Imaging, Three-Dimensional; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; ROC Curve	2016
Diagnostic role of 11C-Pittsburgh compound B retention patterns and glucose metabolism by fluorine-18-fluorodeoxyglucose PET/CT in amnestic and nonamnestic mild cognitive impairment patients. Nuclear medicine communications, 2016, Volume: 37, Issue:11 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amnesia; Amyloid beta-Peptides; Aniline Compounds; Brain; Carbon Radioisotopes; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Radiopharmaceuticals; Thiazoles	2016
Type 2 diabetes mellitus is associated with brain atrophy and hypometabolism in the ADNI cohort. Neurology, 2016, Aug-09, Volume: 87, Issue:6 Topics: Aged; Atrophy; Brain; Cognitive Dysfunction; Corpus Striatum; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Frontal Lobe; Gray Matter; Humans; Male; Positron-Emission Tomography; Sensorimotor Cortex; White Matter	2016
Decreased hippocampal metabolism in high-amyloid mild cognitive impairment. Alzheimer's & dementia : the journal of the Alzheimer's Association, 2016, Volume: 12, Issue:12 Topics: Aged; Amyloid; Aniline Compounds; Atrophy; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Image Processing, Computer-Assisted; Male; Positron-Emission Tomography; Thiazoles	2016
FDG-PET and Neuropsychiatric Symptoms among Cognitively Normal Elderly Persons: The Mayo Clinic Study of Aging. Journal of Alzheimer's disease : JAD, 2016, 07-14, Volume: 53, Issue:4 Topics: Aged; Aged, 80 and over; Aging; Anxiety; Apolipoproteins E; Brain; Cognition; Cognitive Dysfunction; Cross-Sectional Studies; Depression; Female; Fluorodeoxyglucose F18; Humans; Male; Neuropsychological Tests; Positron-Emission Tomography; Psychiatric Status Rating Scales; Psychomotor Agitation	2016
Predicting the transition from normal aging to Alzheimer's disease: A statistical mechanistic evaluation of FDG-PET data. NeuroImage, 2016, Nov-01, Volume: 141 Topics: Aged; Aging; Alzheimer Disease; Biomarkers; Brain; Cognitive Dysfunction; Computer Simulation; Data Interpretation, Statistical; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Male; Models, Statistical; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity	2016
Multimodal Classification of Mild Cognitive Impairment Based on Partial Least Squares. Journal of Alzheimer's disease : JAD, 2016, 08-10, Volume: 54, Issue:1 Topics: Aged; Aniline Compounds; Brain; Cognitive Dysfunction; Dermatitis, Allergic Contact; Discriminant Analysis; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Image Interpretation, Computer-Assisted; Least-Squares Analysis; Linear Models; Magnetic Resonance Imaging; Male; Methacrylates; Multimodal Imaging; Multivariate Analysis; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Support Vector Machine	2016
Differential patterns of regional cerebral hypometabolism according to the level of cerebral amyloid deposition in patients with amnestic mild cognitive impairment. Neuroscience letters, 2016, Oct-06, Volume: 632 Topics: Aged; Aged, 80 and over; Amnesia; Amyloid; Amyloid beta-Peptides; Cerebral Cortex; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography	2016
Clinical impact and diagnostic accuracy of 2-[ Clinical radiology, 2017, Volume: 72, Issue:1 Topics: Adult; Aged; Alzheimer Disease; Cognitive Dysfunction; Comorbidity; Contrast Media; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prevalence; Reproducibility of Results; Risk Factors; Sensitivity and Specificity; Tertiary Care Centers; United Kingdom	2017
Characteristics of mild cognitive impairment tending to convert into Alzheimer's disease or dementia with Lewy bodies: A follow-up study in a memory clinic. Journal of the neurological sciences, 2016, Oct-15, Volume: 369 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Gyrus Cinguli; Humans; Lewy Body Disease; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Retrospective Studies; Visual Cortex	2016
Multimodal characterization of older APOE2 carriers reveals selective reduction of amyloid load. Neurology, 2017, 02-07, Volume: 88, Issue:6 Topics: Aged; Aging; Amyloid; Apolipoprotein E2; Apolipoprotein E3; Biomarkers; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Glucose; Gray Matter; Heterozygote; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neuroimaging; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals	2017
Convergent Results from Neuropsychology and from Neuroimaging in Patients with Mild Cognitive Impairment. Dementia and geriatric cognitive disorders, 2017, Volume: 43, Issue:3-4 Topics: Aged; Alzheimer Disease; Cerebral Cortex; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Neuropsychological Tests; Neuropsychology; Positron-Emission Tomography; Radiopharmaceuticals; Statistics as Topic	2017
Independent value added by diffusion MRI for prediction of cognitive function in older adults. NeuroImage. Clinical, 2017, Volume: 14 Topics: Aged; Aged, 80 and over; Aging; Amyloid beta-Peptides; Cognitive Dysfunction; Dementia; Diffusion Magnetic Resonance Imaging; Executive Function; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Male; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Principal Component Analysis; Regression Analysis	2017
Elevated Neurology, 2017, 03-14, Volume: 88, Issue:11 Topics: Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Carbolines; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography	2017
Early identification of mild cognitive impairment using incomplete random forest-robust support vector machine and FDG-PET imaging. Computerized medical imaging and graphics : the official journal of the Computerized Medical Imaging Society, 2017, Volume: 60 Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prodromal Symptoms; Support Vector Machine; Uncertainty	2017
Neural Basis of Cognitive Assessment in Alzheimer Disease, Amnestic Mild Cognitive Impairment, and Subjective Memory Complaints. The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry, 2017, Volume: 25, Issue:7 Topics: Aged; Alzheimer Disease; Brain; Case-Control Studies; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Male; Memory Disorders; Neuropsychological Tests; Positron-Emission Tomography	2017
Cognitive Composites Domain Scores Related to Neuroimaging Biomarkers within Probable-Amnestic Mild Cognitive Impairment-Storage Subtype. Journal of Alzheimer's disease : JAD, 2017, Volume: 57, Issue:2 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Brain; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Mental Recall; Neuroimaging; Neuropsychological Tests; Organ Size; Positron-Emission Tomography; Prodromal Symptoms; Radiopharmaceuticals; Survival Analysis; Thiazoles	2017
Progressive Disintegration of Brain Networking from Normal Aging to Alzheimer Disease: Analysis of Independent Components of Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017, Volume: 58, Issue:7 Topics: Aged; Aged, 80 and over; Aging; Alzheimer Disease; Brain; Cognitive Dysfunction; Connectome; Disease Progression; Fluorodeoxyglucose F18; Humans; Middle Aged; Nerve Net; Positron-Emission Tomography; Principal Component Analysis; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index	2017
Dynamic changes in PET amyloid and FDG imaging at different stages of Alzheimer's disease. Neurobiology of aging, 2012, Volume: 33, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain; Carbon Radioisotopes; Cognition; Cognitive Dysfunction; Disease Progression; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Humans; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Thiazoles; Time Factors	2012
A visual [18F]FDG-PET rating scale for the differential diagnosis of frontotemporal lobar degeneration. European archives of psychiatry and clinical neuroscience, 2011, Volume: 261, Issue:6 Topics: Aged; Aging; Alzheimer Disease; Atrophy; Brain; Brain Mapping; Cerebrospinal Fluid Proteins; Cognitive Dysfunction; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Frontotemporal Lobar Degeneration; Functional Laterality; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Neuropsychological Tests; Observer Variation; Positron-Emission Tomography; Radiopharmaceuticals	2011
Value of neuropsychological tests, neuroimaging, and biomarkers for diagnosing Alzheimer's disease in younger and older age cohorts. Journal of the American Geriatrics Society, 2011, Volume: 59, Issue:9 Topics: Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cerebrospinal Fluid; Cognitive Dysfunction; Cohort Studies; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; tau Proteins	2011
The use of PIB-PET as a dual pathological and functional biomarker in AD. Biochimica et biophysica acta, 2012, Volume: 1822, Issue:3 Topics: Aged; Alzheimer Disease; Amyloid; Aniline Compounds; Benzothiazoles; Biomarkers; Carbon Radioisotopes; Cognitive Dysfunction; Deoxyglucose; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Parietal Lobe; Positron-Emission Tomography; Regional Blood Flow; Thiazoles	2012
Evidence for astrocytosis in prodromal Alzheimer disease provided by 11C-deuterium-L-deprenyl: a multitracer PET paradigm combining 11C-Pittsburgh compound B and 18F-FDG. Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:1 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzothiazoles; Brain; Case-Control Studies; Cognitive Dysfunction; Deuterium; Female; Fluorodeoxyglucose F18; Gliosis; Humans; Male; Middle Aged; Monoamine Oxidase; Neuropsychological Tests; Positron-Emission Tomography; Radioactive Tracers; Retrospective Studies; Selegiline; Thiazoles	2012
Value of diagnostic tests to predict conversion to Alzheimer's disease in young and old patients with amnestic mild cognitive impairment. Journal of Alzheimer's disease : JAD, 2012, Volume: 29, Issue:3 Topics: Age Factors; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Amyloid beta-Peptides; Canada; Cognitive Dysfunction; Databases, Bibliographic; Disease Progression; Female; Fluorodeoxyglucose F18; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; Predictive Value of Tests; tau Proteins; United States	2012
Combination of biomarkers: PET [18F]flutemetamol imaging and structural MRI in dementia and mild cognitive impairment. Neuro-degenerative diseases, 2012, Volume: 10, Issue:1-4 Topics: Adult; Aged; Biomarkers; Brain; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography	2012
Assessment of dementia risk in aging adults using both FDG-PET and FDDNP-PET imaging. International journal of geriatric psychiatry, 2012, Volume: 27, Issue:10 Topics: Aged; Aged, 80 and over; Cerebellum; Cluster Analysis; Cognitive Dysfunction; Dementia; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neurofibrillary Tangles; Nitriles; Plaque, Amyloid; Positron-Emission Tomography; Radiopharmaceuticals; Risk Assessment; Risk Factors	2012
Toward a dynamic biomarker model in Alzheimer's disease. Journal of Alzheimer's disease : JAD, 2012, Volume: 30, Issue:1 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Hippocampus; Humans; Longitudinal Studies; Magnetic Resonance Imaging; Male; Middle Aged; Models, Statistical; Nonlinear Dynamics; Peptide Fragments; Positron-Emission Tomography; tau Proteins	2012
Predicting missing biomarker data in a longitudinal study of Alzheimer disease. Neurology, 2012, May-01, Volume: 78, Issue:18 Topics: Alzheimer Disease; Amyloid beta-Peptides; Biomarkers; Cognitive Dysfunction; Cohort Studies; Dementia, Vascular; Fluorodeoxyglucose F18; Homocysteine; Humans; Logistic Models; Longitudinal Studies; Magnetic Resonance Imaging; Neuropsychological Tests; Patient Dropouts; Peptide Fragments; Positron-Emission Tomography; Research Design; Risk Factors; tau Proteins	2012
Multi-source feature learning for joint analysis of incomplete multiple heterogeneous neuroimaging data. NeuroImage, 2012, Jul-02, Volume: 61, Issue:3 Topics: Aged; Algorithms; Alzheimer Disease; Artificial Intelligence; Cognitive Dysfunction; Databases, Factual; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neuroimaging; Positron-Emission Tomography; Proteomics; Radiopharmaceuticals	2012
Predicting brain activity using a Bayesian spatial model. Statistical methods in medical research, 2013, Volume: 22, Issue:4 Topics: Algorithms; Alzheimer Disease; Bayes Theorem; Biostatistics; Brain; Case-Control Studies; Cognitive Dysfunction; Computer Simulation; Disease Progression; Fluorodeoxyglucose F18; Functional Neuroimaging; Humans; Magnetic Resonance Imaging; Models, Neurological; Normal Distribution; Positron-Emission Tomography; Radiopharmaceuticals	2013
Posterior parietooccipital hypometabolism may differentiate mild cognitive impairment from dementia in Parkinson's disease. European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:11 Topics: Aged; Case-Control Studies; Cognitive Dysfunction; Dementia; Diagnosis, Differential; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Multimodal Imaging; Occipital Lobe; Parietal Lobe; Parkinson Disease; Positron-Emission Tomography; Tomography, X-Ray Computed	2012
Combination of 18F-FDG PET and cerebrospinal fluid biomarkers as a better predictor of the progression to Alzheimer's disease in mild cognitive impairment patients. Journal of Alzheimer's disease : JAD, 2013, Volume: 33, Issue:4 Topics: Aged; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Predictive Value of Tests	2013
Supporting evidence for using biomarkers in the diagnosis of MCI due to AD. Journal of neurology, 2013, Volume: 260, Issue:2 Topics: Aged; Alzheimer Disease; Amyloid beta-Peptides; Analysis of Variance; Apolipoproteins E; Biomarkers; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Genetic Testing; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neuropsychological Tests; Peptide Fragments; Positron-Emission Tomography; tau Proteins	2013
Amyloid deposition, hypometabolism, and longitudinal cognitive decline. Annals of neurology, 2012, Volume: 72, Issue:4 Topics: Aged; Amyloid; Aniline Compounds; Body Burden; Cognition Disorders; Cognitive Dysfunction; Cross-Sectional Studies; Disease Progression; Ethylene Glycols; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Longitudinal Studies; Male; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography	2012
Whole-brain functional networks in cognitively normal, mild cognitive impairment, and Alzheimer's disease. PloS one, 2013, Volume: 8, Issue:1 Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cognition; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Male; Metabolic Networks and Pathways; Middle Aged; Positron-Emission Tomography	2013
Correction of partial volume effect in (18)F-FDG PET brain studies using coregistered MR volumes: voxel based analysis of tracer uptake in the white matter. NeuroImage, 2013, May-15, Volume: 72 Topics: Algorithms; Brain; Cognitive Dysfunction; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Nerve Fibers, Myelinated; Positron-Emission Tomography; Radiopharmaceuticals	2013
Neuropsychological detection of the early stage of amnestic mild cognitive impairment without objective memory impairment. Dementia and geriatric cognitive disorders, 2013, Volume: 35, Issue:1-2 Topics: Aged; Amnesia; Analysis of Variance; Cognitive Dysfunction; Female; Fluorodeoxyglucose F18; Humans; Intelligence Tests; Japan; Logistic Models; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Neuropsychological Tests; Positron-Emission Tomography; Radiopharmaceuticals; ROC Curve; Wechsler Scales	2013